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Summary  
 This thesis focuses on patient-reported outcome measurements. Through self-report 
questionnaires, quantitative and qualitative methods we have gained an insight into young 
people with type 1 diabetes’ (T1D) self-perceived understanding of health-related quality of 
life and their experiences of own treatment.  
Health-Related Quality of Life (HRQOL) of children and adolescents with type 1diabetes 
(T1D), and the association between HRQOL and mode of treatment, achievement of 
treatment goals and social situation, were assessed through questionnaires completed by the 
patients and one of their parents. Patients were recruited from 21 out of 27 paediatric clinics 
in Norway, and data obtained from the questionnaires were linked to data on diabetic control 
registered in the Norwegian Childhood Diabetes Registry (NCDR). To assess HRQOL, the 
European DISABKIDS Generic Module (DCGM-37) and Diabetes-Specific Module (DDM-
10) were used after translation into Norwegian and validation against the Child Health 
Questionnaire 87 and its parent form, which have been widely used in Norway.  
In addition, a group of adolescent patients’ experiences with two different mobile phone 
applications used for diabetes care were evaluated in a qualitative study. 
 
The psychometric properties of the DISABKIDS instruments were found to be valid and 
reliable in the Norwegian population (study 1). Through the second study, conducted in 
cooperation with the NCDR we were able to assess HRQOL measured by the DISABKIDS 
instruments in a large cohort of young people with T1D. Out of 1967 eligible patients, 937 
(48%) responded.   Boys experienced higher HRQOL than girls, but for both genders poor 
metabolic control was associated with impaired HRQOL. No association was found between 
HRQOL score and treatment modality (i.e. insulin pump versus multi-injections) in this 
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intensively treated population. Parents scored their children’s HRQOL as poorer than the 
children themselves. Compared to similar studies elsewhere in Europe, the Norwegian 
children scored similarly on the DCGM-37, but considerable discrepancies were found when 
comparing the DDM-10 subscales. The low score on the DDM-10 treatment scale indicates 
that the Norwegian population is less adaptive to their treatment (i.e. carrying their equipment 
and planning their treatment).  
 
Twelve adolescents participated in the qualitative study on the development of, and their 
experiences with, two mobile phone applications as a means of contact and guidance between 
themselves and the physician. The results suggest that the mobile phone-based diabetes diary 
gave the participants a new understanding of the cornerstones of treatment through visual 
impression.  
 
The studies suggest that HRQOL issues are important both for psychosocial well-being and 
for achieving treatment goals, and therefore that assessment of HRQOL should be an integral 
part of clinical practice. The experience with the mobile phone application suggests that this 
method may be a way to further develop new educational and communication strategies for 
young people with diabetes and their health care providers. However, randomized 
intervention studies are needed to evaluate the applicability and potential benefits of such 
novel methods in clinical practice.  
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1. Introduction  
Theoretical framework and concepts 
 
 
This introduction is intended to give the reader a general understanding of type 1 diabetes and 
the challenges people living with diabetes face in their everyday life as a background to the 
research questions of the present study. It will also introduce the reader to the concept of 
Patient-Reported Outcome Measures (PROMs), Health-Related Quality of Life (HRQOL) and 
elements of Diabetes Self-Management Education (DSME). 
1.1. Diabetes mellitus 
The term “diabetes mellitus” was introduced by Aretaeus the Cappadocian in Ancient Greek 
medicine around 200 AD. According to the physician, “diabetes” means “to flow through like 
a siphon”, and “mellitus” means “honey”. Aretaeus also described diabetes as a disease that 
“melts down the flesh and limbs into urine”. According to Francis Adams’ translation of 
1856, Aretaeus’ description of the disease runs: “Diabetes is a wonderful affection, not very 
frequent among men … The course is the common one, namely, the kidneys and the bladder; 
for the patients never stop making water, but the flow is incessant, as if from the opening of 
aqueducts. The nature of the disease, then, is chronic, and it takes a long period to form; but 
the patient is short-lived, if the constitution of the disease be completely established; for the 
melting is rapid, the death speedy. Moreover, life is disgusting and painful; thirst, 
unquenchable; excessive drinking, which, however, is disproportionate to the large quantity of 
urine, for more urine is passed; and one cannot stop them either from drinking or making 
water. Or if for a time they abstain from drinking, their mouth becomes parched and their 
body dry; the viscera seem as if scorched up; they are affected with nausea, restlessness, and a 
burning thirst; and at no distant term they expire. Thirst, as if scorched up with fire … Hence, 
the disease appears to me to have got the name diabetes as if from the Greek word “siapftrs” 
(which signifies a siphon), because the fluid does not remain in the body, but uses the man’s 
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body as a ladder, whereby to leave it. They stand out for a certain time, though not very long, 
for they pass urine with pain, and the emaciation is dreadful; nor does any great portion of the 
drink get into the system, and many parts of the flesh pass out along with the urine” (1).  
Type 1 Diabetes  
The onset of diabetes mellitus is still dominated by the same symptoms as those described in 
this ancient text. Due to defective insulin production or defective insulin action it was 
traditionally divided into insulin-dependent diabetes mellitus (IDDM) or type 1 diabetes and 
non-insulin-dependent diabetes mellitus (NIDDM) or type 2 diabetes. A new classification 
system was introduced in 2003 eliminating the terms IDDM and NIDDM (2;3). The terms 
type 1 diabetes (T1D) and type 2 diabetes (T2D) have been retained. In this study we will 
concentrate only on people with T1D. 
 
T1D is one of the most common chronic illnesses affecting children and adolescents. Onset 
can occur at any age, but a peak in incidence is observed around puberty (4). It is a metabolic 
disorder characterized by chronic hyperglycaemia due to defective insulin production. There 
is a considerable geographical variation in incidence of T1D diabetes around the world, with 
low incidence in China and Venezuela ,- 0.1/100000 persons per year  and a high incidence in 
Scandinavian countries (4;5). The incidence of diabetes in Norway ranks as one of the highest 
in the world with 32/100000 persons per year (6;7). In 2011, 2567 children and adolescents 
were registered in the Norwegian Childhood Diabetes Registry, of whom 99% had T1D. 
Intensified insulin treatment, i.e. multi-injection or insulin pump therapy, was used by 97.4 % 
of the population.  
 
T1D is a disease with genetic susceptibility. It is considered to be an autoimmune disease, i.e. 
the body’s defense system, for unknown reasons, attacks and destroys the insulin-producing 
cells of the pancreas, the beta cells (2;8). This specific T cell-mediated autoimmune 
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destruction of the insulin-producing beta cells results in a lack of the hormone insulin. With 
reduced endogenous insulin production the glucose will remain in the blood, resulting in high 
plasma glucose levels. The elevated level of blood glucose leads to spillage of glucose into 
urine, and the lack of glucose entry into the cells leads to incomplete metabolism. These 
disturbances lead to polyuria, polydipsia, weight loss, dehydration, electrolyte disturbance and 
ketoacidosis, and eventually coma and death if not treated with insulin. For thousands of 
years, T1D was a disease with a short and fulminant course and no cure. In 1916, Nicolae 
Paulescue published his reports on the discovery of what he called “pancreine” and his use of 
this purified substance in several animal tests to demonstrate its effect on carbohydrate 
metabolism (cited from 9). However, Banting and Best were awarded the Nobel Prize for the 
discovery of insulin following their reports of the discovery, purification and demonstration of 
insulin’s physiological activity (10). In many ways the cure for diabetes had been found, and 
from then on extracts of animal insulin were utilized to treat the disease. The molecular 
structure of the hormone was disclosed during the 1960s and 1970s, and synthetic (human) 
insulin was approved for pharmaceutical use in 1982.  
 
In 1986, results from the Oslo study indicated that near-normoglycaemia induced by insulin 
pumps (CSSI) or multiple daily injections (MDI) delayed the development of long-term 
complications (11). This was confirmed by the Diabetes Control and Complications Trial 
(DCCT) study which demonstrated significantly better long-term outcomes for intensive 
treatment given by multi-injections or insulin pumps than with more conservative treatment 
modalities, i.e. one or two daily injections (12). These studies also inspired the search for 
other and better types of insulin and the introduction of faster-acting insulin analogues in the 
1990s and longer-acting insulin analogues in the 2000s. In Norway, intensified insulin 
regimens, which include a rapid-acting insulin analogue at each meal combined with long-
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acting insulin analogues one-two times daily or continuous subcutaneous insulin infusion with 
insulin pumps, are now more the rule than the exception (13).  
 Diabetes as a systemic disease 
Diabetes is not only a lack of insulin and high levels of plasma glucose, but also a systemic 
disease with major implications for patients who encounter serious short-term challenges 
including risks of acute complications, hypoglycaemia and diabetes ketoacidosis (DKA). The 
metabolic change that affects the whole body also includes long-term complications, 
including serious effects on the cardiovascular system. These changes in micro- and macro-
vascular systems result in cardiovascular disease and premature death, severe visual 
impairments, including blindness, renal failure and neuropathy (14-22). These long-term 
complications can, to a large extent, be prevented by optimal blood glucose control (11).  
1.2. Psychosocial aspects  
The awareness of the psychosocial implications of diabetes is clearly presented in the 
International Society for Pediatric and Adolescent Diabetes (ISPAD) Consensus Guidelines 
from 2000: ‘‘Psychosocial factors are the most important influences affecting the care and 
management of diabetes” (23). A huge body of literature also highlights the importance of 
psychosocial factors (24-27). It is suggested that this might be due to the burden of daily 
treatment, and the fear of short- and long-term consequences (28-30). The disease has a great 
impact on daily life for the patients and their families, and it is known that psychological 
aspects and the total well-being affect the daily treatment of this chronic condition (24;29;31-
36). Family structure, communication and relations within the family play major roles in the 
achievements of goals (27;35). Peer relations are also reported to have an impact on self-
treatment routines (37). 
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It is common to have adjustment problems soon after the diagnosis, even though most 
children and adolescents resolve these problems. Those who do not, are at risk of poor 
metabolic control and continued psychosocial difficulties (38;39). Behavioural problems at 
diagnosis seem, however, to be associated with mental problems later in life (40). 
Psychosocial problems may counteract optimal diabetes care and achievement of treatment 
goals (24;38;41-43). The presence of diabetes-related complications and anxiety are 
correlated with lower physical and psychosocial functioning. Increased co-morbidity in terms 
of affective disorders and other psychological or mental difficulties are reported in young 
diabetics (44-48). In one of the first studies to look at the relationship between depression and 
adaptation to diabetes, Lernmark and co-workers concluded that the identification of the 
patients with depression is important in order to be able to increase their ability to deal with 
their diabetes (49). Studies have shown that paediatricians are highly specific, but have a poor 
sensitivity for detecting psychiatric co-morbidity among patients (50). It has therefore been 
suggested to apply routine screening for psychosocial implications of chronic diseases in 
paediatric care (38;51). One way to assess this is through instruments that measure HRQOL. 
De Wit et al. were the first to report from a randomized controlled study that monitoring and 
discussing HRQOL with young people with T1D improved psychosocial well-being and 
treatment satisfaction (52). Further, the same groups reported that the beneficial effect 
disappears after one year. This underlines the importance of routine evaluation and discussion 
of HRQOL in routine care (53). In this thesis we have assessed HRQOL among children and 
adolescents with T1D in Norway.  
1.3. Glucose control and HBA1c 
The intermittent self-monitoring of blood glucose (SMBG) determines the capillary glucose 
level at the moment when tests are performed. This method has revolutionized the 
management of diabetes.  In 1978 a new measure of long term blood glucose control was 
introduced  (54). Glucose is irreversibly attached to the haemoglobin molecules in the red 
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blood cells, forming glycated haemoglobin (HbA1c). The formation of HbA1c is proportional 
to the concentration of plasma glucose (55). The measured HbA1c therefore reflects glucose 
levels over the preceding 4-12 weeks and can be used as a test to evaluate metabolic control 
(56;57). It is also the only biological measure for which good data are available in relation to 
the development of micro- and macro-vascular complications (58). The international society 
of paediatric and adolescent diabetes (ISPAD) guidelines recommend a treatment goal of 
HbA1c< 7.5 %. 
1.4. Diabetes treatment  
Over the last 20 years there has been a radical change in the treatment of type 1 diabetes and 
today’s treatment is tailored and based on self-management. The treatment goals are hard to 
achieve and come at a high price for young people, as they include rigorous daily routines 
where the main goal is to maintain healthy blood glucose levels. Treatment goals might be 
achieved by tailoring the insulin dosages to blood glucose measurements and actual food 
intake while taking into account physical activity. These four elements are described as the 
cornerstones of diabetes self-management. However, in spite of SMBG, new insulin 
analogues, insulin pens and pumps, and improved support from diabetes teams and patient 
organizations (59), patients and their carers struggle to achieve treatment goals, especially 
when the patients enter their teenage years. It is reported that more than 50% of patients 
internationally do not obtain adequate metabolic control (36). Less than 30% of Norwegian 
children and adolescents achieve treatment goals of HbA1c<7.5% (13;60). The relationships 
between metabolic control and development of competences to implement self-treatment 
involve many mediating variables. It is predictable that different competences both in the 
child itself and among their significant others affect diabetes self-management.  
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1.5. Competences 
Competence used as a substantive comes from the Latin words cum – together and petere – 
seeking out. This makes sense in the diabetes setting, as both the patients and health -care 
providers need to seek out the various factors that affect insulin dosages and glucose 
measurements. Socrates described competent individuals as “those who manage well the 
circumstances which they encounter daily, and who possess judgment which is accurate in 
meeting occasions as they arise and rarely miss the expedient course of action” (61) p155).. 
Physiological and psychological variations, social interactions, as well as health-related 
quality of life, knowledge and skills are all variables that affect and mediate action in young 
people living with a chronic disease. The traditional understanding of competence is 
frequently seen as a combination of knowledge, skills, attitudes and behaviours that an 
individual is competent at; in other words, competence has traditionally been seen as an 
ability to deliver or perform tasks with relative ease and with a high level of predictability in 
terms of quality and timeliness (62). We know that modern diabetes self-care requires 
advanced knowledge and practical skills (58;63). However, the use of these competences is 
subject to negotiations according to the contexts of the everyday lives of people living with 
diabetes. It is important to remember that people visit their doctor three-four times a year for 
30-45 minutes. The organization “Ungdiabetes” in Norway estimated the time left alone with 
your diabetes to be 99.97% of the year. This highlights the fact that health-care providers are 
also challenged by time in order to get to know their patients and it is pretentious to expect 
that these short meetings have a large effect on daily self-care. Furthermore, in almost no 
other chronic condition is the achievement of “competent self-management” so critical. We 
know that the adolescent phase as a transitional period in itself is a challenge for young 
people, and for their carers. An additonal chronic disease makes this period of adaptation an 
even greater challenge. Rigorous self-care is particularly difficult for children and adolescents 
who want an independent lifestyle like their peers (41). The parents are often in charge of 
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treatment during childhood, and the gradual transfer of daily responsibility and daily routines 
in late childhood seems to be important in order for the adolescents to be competent and 
capable of taking care of their own daily self-management (63).  
 
Used in our context, competence is related to the attempts to master various tasks in different 
settings when living with type 1 diabetes. The action competence concept helps us to focus on 
children and young people as acting subjects in their daily life (64). While an “individualistic-
mentalistic approach” to competence development considers this as a process situated inside 
the individual, the “situated learning approach” explains competence development as 
continuously ongoing processes situated in and affected by different socio-cultural contexts 
(65). “The action competences of children and youth develop dynamically over time. This 
development is complex and happens as a result of children’s participation in and across 
different practices within different contexts” (66) (Figure 1). It is claimed that children and 
adolescents who experience social and/or health problems have a tendency to develop 
alternative strategies and practices to tackle their daily life. This may implement coping 
strategies and action competences which promote and/or maintain dysfunctional behaviour as 
an alternative way to reduce the outer and/or inner stressful complexity of their life (64). 
 
Figure 1: The ongoing 
transformation of action 
competencies, where the 
individual is confronted 
with new demands in 
new or changed contexts 
(from (65)). (Reproduced by 
permission.) 
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It might be beneficial when we do research on the psychosocial consequences of type 1 diabetes 
to be aware of action competences thought to be relevant in order to master tasks for living 
with type 1 diabetes. External conditions and social practices in different activities among 
family and friends, at home or school, in leisure activity or at work mutually affect young 
people with T1D and their action competencies. The Norwegian psychologist Jon Haug has 
suggested in his thesis that the most important competence for people living with diabetes is 
to acquire a mental, or rather psychological, need for insulin in order to replace the 
physiological beta cell response to carbohydrate intake (67). In order to facilitate such an 
integrated, psychological competence, we need to continuously search for factors and 
strategies that make this competence development possible.  
The adolescent brain is “a work in progress”. In child and adolescent medicine it might be 
useful to take into account the novel understanding from longitudinal studies on brain 
development through the child and adolescent phase using magnetic resonance imaging 
(MRI) (68;69) (Figure 2).  
  
Figure 2: Right lateral and top views of the dynamic sequence of grey matter maturation over 
the cortical surface. The side bar shows a colour representation in units of grey matter 
volume. The initial frames depict regions of interest in the cortex (from Gogtay (69) (Reproduced 
by permission.) 
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Diabetes self-care is highly dependent on coordination of thoughts and behaviour, i.e. 
executive functions. The skills necessary for such coordination are ”selective attention, 
decision-making, voluntary response, inhibition and working memory (70)”. We now that 
motor and sensory brain areas mature first and especially that the occipital pole containing the 
primary visual cortex matures early, with later maturation in areas involved in executive 
functions (69). This might facilitate the use of modern technology making use of visual 
imaging in this particular patient group. Reports show that simple visual tools designed by 
young people in their own personal settings seem central to developing patients’ 
comprehension, recall and adherence (71;72).  
1.6. Diabetes education 
Recommendations on diabetes treatment highlight the importance of diabetes self-
management education (DSME). National standards for DSME have been designed by the 
American Diabetes Association (ADA) to define quality diabetes self-management education 
and to assist diabetes educators to provide evidence-based education (73). A definition of 
diabetes education has been suggested as “the process of providing the person with the 
knowledge and skills needed to perform diabetes self-care, manage crises and to make 
lifestyle changes to successfully manage the disease” (74). However, despite 
recommendations and widespread use of educational programmes there is little scientific 
evidence of the effect of and development of self-care support programmes among children 
and adolescents (75-77). Various practices both in dietary intake and health-care providers’ 
approach to insulin self-treatment in different clinics and countries make studies difficult to 
compare (78). Reviews, call for well-designed, standardized DSME interventional trials that 
involve parents and children and are developmentally appropriate and feasible for inclusion in 
daily health care (75;79).  
It is clear from group discussions with young people that education using new technologies 
might be attractive, but there is little evidence to support this notion (80). In their article 
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“Diabetes education in children and adolescents – what do adolescents want?”, Chaney et al. 
highlight that interventional programmes need to be designed in collaboration with 
adolescents and their families (81). Further, they conclude that follow-up post-education 
presents a challenge to health care practitioners as the adolescents participating in the study 
only wished to communicate by text message (81). The literature seems to agree that there is 
still a long way to go to find the best DSME and that future programmes need to be developed 
in collaboration with the end-users and their families if we are to get closer to successful 
management of diabetes. 
1.7. Patient-reported outcome  
In recent decades there has been a shift in focus to involve patients in treatment decisions. This is 
reflected in international treatment recommendations and national strategies (51;82;83). “Patient-
Reported Outcome Measures (PROMs) are tools we use to gain insight from the perspective of 
the patient, into how aspects of their health and the impact of their disease and its treatment are 
perceived to be having on their lifestyle and subsequently their quality of life (QOL). They are 
typically self-completed questionnaires” (84). In addition, patient-reported outcome could also 
be assessed by exploring patients’ experiences and perceptions in a systematic manner. Despite 
international initiatives and national policy, to our experience and according to unpublished 
reports from NCDR, the inclusion of formal validated questionnaires in routine clinical work in 
Norwegian diabetes outpatient clinics is rare or non-existent. Patient-reported outcome measures 
can guide health-care personnel in making treatment decisions; they can be used to monitor 
outcome and are suitable for providing a baseline assessment of self-perceived health status, 
quality of life, etc. (84). Further, they are useful for communicating health-care needs to health-
care practitioners (85;86). In both research and clinical work it is recommend that PROMs are 
selected based on content, psychometric properties and alignment with the issues we aspire to 
understand better (87). 
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1.8. Quality of life (QOL) as a construct 
Quality of life is a broad concept, with no universal definition, making it difficult to 
comprehend, and not least difficult to utilize as a joint working instrument in clinical and 
scientific work. It is a hypothetical construct and therefore cannot be observed. When dealing 
with the QOL concept a lot of different macro and micro systems and various perspectives 
and variables are discussed. QOL models that incorporate different academic traditions have 
been suggested, implementing sociological, economical, psychological, philosophical and 
ethical aspects of a person’s life. The measures of QOL should therefore be viewed as 
indicators of underlying characteristics often referred to as a latent trait or process (88). 
Theoretical concept models with respect to global quality of life have been suggested. These 
models traditionally incorporate five wide-ranging domains: the biological, psychological, 
interpersonal, social and economic experiences of a person. Mattejat and colleagues presented 
the basic concepts of QOL in children and adolescents (Mattejat 1998) and this was later 
developed into a figure by Jozefiak (Figure 3) (87 p16).  
 
 
 
 
 
 
 
 
 
Figure 3: Basic aspects of quality of life. (Reproduced by permission.) 
 
Objective preconditions for 
Quality of life 
e.g. Material preconditions, 
somatic or mental disease, 
psychosocial factors, 
medical treatment that may 
increase or decrease QOL 
The ability to act and 
functioning level 
e.g. achievements provide an 
“objective” QoL that can 
best be evaluated from an 
external perspective  
Well-being and 
satisfaction 
“Inner quality of life” is a 
subjective QOL that can 
best be evaluated by child 
report, according to 
his/her own experiences  
Quality of life in a narrow sense 
Quality of life in a broad sense 
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Most models of quality of life emphasize the distinction between the experience of life and 
life conditions, and social researcher and head of department in the Department of Social 
Policy and Social Work at the University of Manchester Beverley Hughes has suggested 
another conceptual model of quality of life and highlights the interacting system of factors 
which together define and assess quality of life (Figure 4) (89). 
 
Figure 4. A conceptual model of quality of life (after Hughes (89) p55). (Reproduced by permission.) 
 
While it is obvious that experiences are subjective, life conditions are more objective 
parameters. Integration of both subjective and objective elements into the concept of QOL 
increases the complexity of the construct. It is also emphasized that general measures of QOL 
are useful for comparison across populations, but it is questioned whether they are sensitive to 
unique aspects of particular diseases (90). Further, the health system does not have 
instruments to affect all the elements implemented in the broader QOL construct. In an 
attempt to constrict the concept of QOL into a patient-reported measure, some researchers 
have suggested the concept of health-related quality of life (91;92).  
 
1.9. Health-Related Quality of Life (HRQOL) 
HRQOL is a construct designed to capture essential aspects of psychosocial outcome in 
people with chronic health conditions (92). HRQOL is seen as a multidimensional construct 
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and is defined by referring to “the physical, psychological and social domains of health, seen 
as distinct areas that are influenced by a person’s experiences, beliefs, expectations and 
perceptions” (93). The World Health Organization (WHO) declared in 1948 that health is a 
state of complete physical, mental and social well-being and not merely the absence of disease 
or infirmity (94). In 1993, the WHO published recommendations important for HRQOL 
measurements among children and adolescents (95). Most HRQOL instruments tailored for 
young people therefore comprise the physical, mental and social domains. HRQOL indicates 
the impact of a medical condition or disease on an individual’s physical, emotional and 
contextual well-being (96;97).  
1.10. Developing test instruments, conceptual background, validity and 
reliability 
Designing and developing instruments to be used in HRQOL studies is a complex process 
(98;99). As already mentioned, most HRQOL instruments are based on a definition of 
HRQOL that includes mental, social and physical components, making this a relatively broad 
psychosocial construct. HRQOL instruments are available both as generic and disease-
specific instruments, as well as for both general populations and people with chronic diseases. 
The use of HRQOL measure has to a large extent focused on adults. However, there 
has been a growing interest in assessing HRQOL in children and adolescents over the last few 
decades (99;100). It is important that such instruments are age and developmental appropriate, 
and they should be adapted culturally to the population targeted (95). The European Union 
(EU)-initiated DISABKIDS instrument is the only HRQOL instrument developed across 
cultures for children with chronic diseases, and it has been developed in a bottom-up process 
including focus groups and field testing among European children and adolescents with 
chronic diseases (98;101). To a large extent, therefore, this EU-initiated project has taken into 
consideration the criticism raised in literature towards the lack of cross-cultural HRQOL 
instruments for children with chronic conditions. The EU-initiated DISABKIDS project 
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followed a rigorous methodology (Table 1) that emphasizes the subjective evaluation of 
symptoms. It is unique in its cross-cultural development, the modular system and the 
combination of specific and generic aspects, as well as the wide age range and the 
representation of parents’ and children’s views (98).   
Table 1: Overview of the methodology in the DISABKIDS project. 
Litterature review 
Focus groups 
Item development 
Translation 
Pilot testing 
Field testing 
Implementation study  
Final report  manual  
 
 
This methodology also ensured the validity and reliability issues related to such instrument 
development as described in the DISABKIDS handbook. Concerns on cultural variations are 
important in every step from the conceptual and construction level through cross-cultural 
focus groups, pilot and field testing and final implementation. Further, when applying cross-
culturally developed instruments to new populations, we nevertheless have to deal with the 
items through the translation phase and the psychometric testing phase, to ensure that the 
instruments to be used really assess what they intend to measure and that this really mirrors 
the underlying constructs. Guidelines have been published to ensure this process (102). These 
international guidelines were the basis for the translation and validation procedures of the 
Norwegian version and also included convergent validation against a valid and widely used 
HRQOL instrument, the Child Health Questionnaire CHQ-87 and the Child Health 
Questionnaire Parent Form CHQ-PF (article1).
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The DISABKIDS GENERIC INSTRUMENT - DCGM-37 
The basic structure of domains of the DISABKIDS generic instrument as an HRQOL 
measurer is summarized in Figure 5. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: The structure of the DISABKIDS Chronic Generic Module 37 (DCGM-37), 
including rephrased, positive subscales (in parenthesis) (98;103). 
 
 
However, in order to comprehend the concept of HRQOL and the DCGM-37 in particular, we 
need to be aware that all responses to questions in such instruments will also be affected by 
other factors and life conditions beyond health alone. In Figure 6, we have implemented some 
of these factors to display the other aspects thought to affect the responses to questions in an 
HRQOL instrument like DISABKIDS.  
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Figure 6: The DISABKIDS generic instrument (original version) placed in and surrounded 
by the “tentacles” of general life conditional factors that to a larger or lesser extent influence 
experiences, beliefs, expectations and perceptions and through this the individual HRQOL 
score.( Frøisland 2012) 
 
The DISABKIDS Diabetes instrument DDM-10 
The diabetes specific instrument DDM-10 (Figure 10) is more directly focused on the impact 
(acceptance) and treatment of the disease, making the responses on these scales less 
dependent on general life conditions. Nevertheless, it is important to be aware that individual 
responses are affected by the total life conditions of the respondents. 
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1.11. Information and communication technology and electronic health 
 
There has been a rapid development in information and communication technology (ICT) in 
recent decades. This development applies to the health-care area as it is thought to ease the 
flow of information between the health care workers and their patients (104;105). Health-care 
providers recognize that these new technologies might be useful in preventing, diagnosing, 
monitoring and treating chronic diseases (106). Technologies apllied include the Internet, 
email and mobile phone applications, and are frequently referred to as “electronic health” or 
“eHealth” (107).  
The use of ICT to facilitate health care has over the last twenty years been dominated 
by computer technology using personal computers (PCs) (105). Many ICT studies report 
overall positive results and there are evidence that ICT-based interventions improve health 
care utilization, health behaviours, attitudes, skills and knowledge (105). Over the last decade, 
studies involving mobile phones in relation to health care have been published (106;108-111). 
Few studies have been carried out among children and adolescents with type 1 diabetes.  
When developing a new ICT system, user-involved design of patient-operated systems 
is advocated in order to forward useful applications (112). Wagner’s Chronic Care Model 
suggests that the patient-provider interaction should ensure “behaviourally sophisticated self-
management support that gives priority to increasing patients’ confidence and skills so that 
they can be the ultimate manager of their illness” (113). Based on this philosophy, the 
Norwegian Centre for Integrated Care and Telemedicine has developed and tested several 
mobile applications based on user-participatory design processes.
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2. Aims and objectives 
 
Aim of study 1: To test and validate the DISABKIDS HRQOL instruments for the Norwegian 
child and adolescent diabetes population.  
 
Aims of study II: To investigate psychosocial well-being measured by the DISABKIDS 
health-related quality of life instruments in children and adolescents with type 1 diabetes and 
to test the associations between total HRQOL score and level of metabolic control (HbA1c), 
frequency of acute complications, and socio-demographic factors. Finally, we wanted to 
examine whether there are detectable differences in HRQOL scores between those using an 
insulin pump and those on multiple daily injections. 
 
Aims of study III: To evaluate by mixed methods; i.e. qualitative interviews,  metabolic 
control (HbA1c), a system usability scale (SUS) and diabetes knowledge tests the usability of 
and experiences  with  two different mobile phone applications  applied by adolescents with 
type 1 diabetes when involved in a three-month trial. Further, the aim was to explore how 
applications for mobile phones can be used in follow-ups on adolescents with type 1 diabetes, 
and to use the findings to guide further development of the applications. 
 
The general aim of this project was to lend an ear to the real experts, the people living with 
the disease, to explore and report on their own experiences, and pass this on to a broader 
public. We report on the present state in relation to HRQOL among Norwegian children and 
adolescents with diabetes as well as describing future options and possibilities in order to 
affect competence, applied knowledge and treatment behaviour and possibly affect future 
HRQOL among children and adolescents living with diabetes.
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3. Material and methods 
 
The collection of data and range of scientific methods used in this study vary according to the 
aim of each sub-study (table 2). In order to uncover a broader understanding of competences, 
experiences, challenges and associations in relation to young people living with diabetes we 
utilized both quantitative and qualitative data and research methods.  
Three separate studies were performed. The first collected data from three different outpatient 
clinic populations in South Eastern Norway. Data were collected through paper-based 
HRQOL questionnaires. Scores from the HRQOL questionnaires were merged with 
biophysical variables from the NCDR. In the second study, questionnaires were distributed to 
all participating centres in the NCDR. Paper-based questionnaires were returned to the 
registry, and the data from this study were merged with variables from the annual case report 
forms reported to NCDR in 2010. In the third study, a mixed-methods design was applied, i.e. 
interviews, two different questionnaires and metabolic control measured by HbA1c. An 
overview of methods, participants and samples according to the different studies carried out is 
described in article 1, 2 and 3 respectively. 
Table 2: Overview of the research methods, populations and data collection in the three 
different studies. 
Study  Method Participants Data collection 
period 
Data collection method 
Study I Quantitative Children and adolescents from 
3 different hospitals in South-
Eastern Norway Regional 
Health organization ( N103) 
2009 Self-completed questionnaires. 
Clinical variables from the 
Norwegian Childhood Diabetes 
Registry (Barnediabetesregisteret) 
Study II Quantitative Patients >8<20 years of age 
registered in the Norwegian 
Childhood Diabetes Registry 
(Barnediabetesregisteret)(N937) 
and their parents . 
 
2010-2011 Self-completed questionnaires. 
Clinical variables from the 
Norwegian Childhood Diabetes 
Registry (Barnediabetesregisteret) 
Study III Qualitative Children and adolescents from 
2 different outpatient clinics in 
Innlandet Hospital trust  
(N 12) 
2010 Semi-structured interviews. System 
Usability Scale and knowledge tests. 
Clinical parameters collected from the 
two hospitals. 
21 
 
3.1. Participants 
The Norwegian Childhood Diabetes Registry (NCDR) is a population-based, nationwide 
registry covering all paediatric departments in Norway. Since 2009, all departments in 
Norway have participated in this registry. In 2010, 95% of all children and adolescents with 
diabetes treated by paediatricians were included in the registry (13). The registry has collected 
data through the case record form (CRF) translated and modified from the WHO Basic 
Information Sheet for children and adolescents (114). It contains detailed reports on 
biophysical parameters as reported in Table 3. Since the year 2000 the participating centres 
have reported a CRF for each participant from an annual visit to NCDR. The registry punch 
paper-based data into coded files and associated studies can apply through the board to 
acquire data from the registry. In study 1 and 2, such data were provided by NCDR. Paper-
based instruments for HRQOL data were scanned using Tele Form and merged with the 
biophysical data from NCDR.  
Table 3: Variables collected as quality indicators and benchmark variables in case report 
form in the Norwegian Childhood Diabetes Registry. 
Standardized HBA1c 
measurement  
Treatment modality Amount and type of  insulin per 
day 
Number of blood glucose 
measurements per week (4-week 
recall period) 
Number of consultations last 
year 
Number of injections per day (4-
week recall period) 
Number of events of 
hypoglycaemia with seizures or 
unconsciousness last year 
Number of events of 
hypoglycaemia with the need of 
help (4-week recall period) 
Number of days in hospital due 
to diabetes (last year) 
Number of events of 
ketoacidosis with hospitalization 
last year 
Contact with dietician (last year) Familiar diabetes onset or 
cardiovascular event last year 
Eye examination Retinopathy Treatment of eye complications 
(laser) 
Urine albumin Medical treatment due to high 
blood pressure or epilepsy 
Blood lipids 
Nerve examination Other autoimmune disorders (i.e. 
celiac, thyroid and Addison’s 
disease) 
Examination of insulin injection 
sites 
Height  and weight Pubertal status Smoking status  
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Biophysical data from the registry for participants aged above eight years participating in the 
NCDR are used as background data in studies 1 and 2. 
Study 1 
The study population in regard to study 1 (article 1) is shown in Figure 7. A relatively large 
proportion of the total eligible child-parent dyads did not want to participate or were never 
approached for participation. 
 
Figure 7: The study population in regard to article 1 is as shown in Figure 1. 
 
 
Study 2 
 The study population in regard to study 2 (article 2) is shown in Figure 8. In our reports we 
have used a calculated response rate from the total number of eligible children and 
adolescents at each centre when calculating our response rate. We requested the participating 
centre to report the exact number of patients not approached, but due to the complexity of our 
study design, the workload in the clinics and the substantial numbers of health-care personnel 
involved in these reports, only 14 centres reported this number, and the reported data were 
suboptimal. In our paper (paper2) we therefore calculate our participation rate based on the 
 
 
Eligible child parent dyads 
198 
N 198 
Participated  
N 103 (52%) 
Did not want to participate 
or was never approached 
for participation due to 
work overload in the 
departements 
N 95(48%) 
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total number of eligible child-parent dyads at the 21 participating centres. However, in Figure 
8, the report of 255 child-parent pairs not approached is shown. This is further discussed on 
page 48. 
 
 
FIGURE 8: Flow chart of total eligible population and non-participants versus participants in 
study 2. 
Study 3 
The study population in regard to article 3 was recruited from two different outpatient clinic 
populations in Eastern Norway (Gjøvik and Lillehammer) (n 12).
Total number of children 
and adolescents above 
eight, eligible for study 2  
N2227 
Eligible child parent dyads at 
21 centers around Norway  
N:  1967 
Non participants 
N=1030 
Reported not 
approached  
N =255 
Approached for 
participation 
N=775 
Children /adolescents  
participating 
N: 937 
Child parent dyads at 
centers 7, 27 abstaining 
from study 
N:   43 
Child parents dyads at center 
reporting problems with 
implementation  of the study -
centers excluded from study    
N:  217 
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3.2. Data procedures 
Study 1 
Instruments used were patient self-report on paper copies of DCGM-37, DDM-10 and CHQ-
CF87. Proxy report by one of the participants’ parents were obtained on the parent versions of 
DCGM-37, DDM-10 and CHQ-PF. In study 1 and 2 a standard manual detailing the data 
collection was distributed to each of the participating centers (Appendix 1) and a information 
brochure was sent by post prior to one of the patients consultations (Appendix 2). 
Study 2 
Instruments used were patient self-report on paper copies of DCGM-37and DDM-10. Proxy 
reports by one or both of the parents were obtained on parent versions of DCGM-37, DDM-
10 and response on questionnaire regarding socioeconomic parameters.  
Study 3 
Data collection was through semi-structured interviews. In order to apply a broader view, 
triangulation of methods was used and three additional measurements were applied: change in 
metabolic control, measured by HbA1c before and after the intervention period, the System 
Usability Scale after, and knowledge tests before and after the 12-week period. 
 
3.3. Questionnaires  
DISABKIDS Instruments (Study 1, 2) 
 
As previously reported, the DISABKIDS questionnaire was used in studies 1 and 2. The 
DCGM-37 questionnaire contains 37 items which explore six dimensions of HRQOL 
(115;116) (Figures 5), Appendix 3, 4 (child/adolescent version), Appendix 5, 6 (parent 
version). 
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 “Mental independence assesses whether the child feels confident about the future and is able 
to live an autonomous life without impairments caused by the condition; Mental emotion 
(Inner strength) addresses emotional reactions, such as worries, concerns, anger and problems 
caused by the child’s condition; Social exclusion (Social equality) deals with the feeling of 
being left out and stigmatized; Social inclusion focuses on positive social relationships and 
the understanding of others; Physical limitation (Physical ability) refers to somatic limitations 
due to the condition; and Physical treatment assesses the impact of taking medication, 
receiving injections, etc” (98;103).  
Due to the fact that the instruments are based on both positive and negative statements, the 
scales original names are also phrased in the same manner. Since scales for negatively worded 
items are reversed, higher scores will indicate less impact of the disease on all domains. It is 
difficult to comprehend how someone may present a high score on both social inclusion and 
social exclusion subscales, and it has been claimed that this makes the presentation of 
HRQOL results difficult to transfer into clinical relevance (117). Osobo et al. have therefore 
suggested that HRQOL results would be more meaningful if negative domains were 
reconceptualised to positive statements (118;119). In this thesis, therefore, similar to the 
presentation of the results of DISABKIDS from Sweden (119) as well as in our own studies, 
“Mental emotion” is rephrased as “Inner strength”, ”Social exclusion” as “Social equality”, 
and “Physical limitations” as “Physical ability”. In DDM-10, the “Diabetes impact” scale is 
renamed “Diabetes acceptance” (119).  
“Each item in DCGM-37 and DDM-10 is scored on  five-point Likert scale indicating 
frequency of behaviours or feelings as 1 = never, 2 = seldom, 3 = quite often, 4 = very often, 
5 = always. According to the manual, the scales for negatively worded items are reversed. In 
computation of sum scores, missing values are substituted by the mean of the non-missing 
items if only one item of the domain is missing. If more than one item is left out the domain is 
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not scored. The sum score of each domain is the sum of the single-item scores. This raw score 
is transformed to a sum score for each domain ranging from 0 to100. From these a total score 
may be computed with a range from 0 to 100 with higher scores indicating higher self-
perceived HRQOL” (103).  
DISABKIDS Diabetes Module 10 
The diabetes specific instrument (DDM-10) consists of an “Impact” scale (“Acceptance”) and 
a “Treatment” scale (Figure 10).  
 
Figure 10: The structure of the DISABKIDS Diabetes Module 10 (DDM-10). 
 “The “Impact scale” (“Acceptance”) deals with emotional reactions to blood glucose control 
and adhering to diets in everyday life, and the “Treatment scale” deals with emotional 
reactions to the planning of treatment and the burden of carrying equipment” (120). 
In line with international scientific translation procedure recommendations, our group forward 
and backward translated the DCGM-37 and DDM-10 forms from English to Norwegian (98). 
The goal of this process was to keep the original meaning of the questions and simultaneously 
to find the most appropriate terms in the new language. The final versions were approved by 
the DISABKIDS research group.  
 
DDM-10 Subscales 
DDM-10 
Impact 
(Acceptance) 
Treatment 
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Child Health Questionnaires (Study 1) 
Child Health Questionnaire 87/Child Health Questionnaire Parent Form 
In addition to the DISABKIDS questionnaires, the children and adolescents also filled in the 
Child Health Questionnaire Form 87 (CHQ-CF87) (Appendix 7), and their parents the Child 
Health Questionnaire Parent Form 50 (CHQ-PF) (Appendix 8). The CHQ-CF87 is a generic 
HRQOL questionnaire designed to measure physical, emotional, behavioural and social well-
being (121). CHQ-CF87 is recommended for independent response  by children above 10 
years of age, while the questions could be read to younger children (122;123).  
The effect that health implies is assessed over several domains (103;124). The responses are 
indicated on four- to six-point Likert items describing frequency of behavior or feelings 
ranging from “very often” to “not at all”. The items form scales and responses on items within 
each subscale are summed into raw scores and  transformed to a score between 0 and 100. 
Higher scores indicate better functional health and well-being. “Extensive studies on the 
psychometric properties of the CHQ-CF87 and CHQ-PF50 suggest strong internal 
consistency, content validity and construct validity. Translation into Norwegian had been 
carried out previously, and the instruments have been used in several Norwegian patient 
cohorts (25;125;126). Except for the “Change in health” and “Family cohesion” items, which 
refer to last year, and the “General health” scale, which has no recall period, a four-week 
recall period is used for each scale” (103).  
Additional parameters (Study 1, 2) 
As described above (under study 1), the DCGM-37 and DDM-10 questionnaires were used to 
partly assess psychosocial factors thought to influence daily HRQOL in children and 
adolescents living with diabetes. In addition to the NCDR annual collection of data we also 
collected socio-demographic background factors from the responding parents and used these 
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in our analyses. Children from 8 to 10 years were asked to respond to the DISABKIDS 
instruments only. Children and adolescents above 11 were asked to respond to a larger 
instrument panel, as will be analysed later. Parents were also asked to respond to the extended 
instrument package as well as socio-demographic factors.  
3.4. Quantitative data analyses 
The completed questionnaires were scanned using TeleForm (Cardiff Software, Vista, CA) 
and 10% randomly selected and checked for scanning errors. All the scanned data are stored 
in the research database at Oslo University Hospital, Ullevål. Scoring data are reported as 
means, with one standard deviation (SD); significance was defined as P < .05. Floor and 
ceiling are reported in numbers and/or in percentage of the total participants. We used IBM’s 
statistical package for the social sciences (SPSS) version 18.0 (IBM Corporation, Somers, 
NY, USA) for the analyses.  
Study 1  
For the DISABKIDS questionnaires, reliability was assessed by tests of internal consistency 
of each of the subscales and the overall sum score. Cronbach’s alpha coefficients above 0.70 
are generally viewed as sufficient when instruments are used for group-level analysis 
(99;127). The two DISABKIDS instruments consist of short scales with less than 10 items in 
each scale; literature suggests that reporting on mean inter-item correlations in such cases 
might be more appropriate than the Cronbach’s alpha. Upper and lower limits of mean inter-
item correlations are a matter for discussion (103). Some authors claim that values between 
0.2 and 0.4 are optimal (128), while others argue that a mean inter-item correlation 
consistently above 0.70 may indicate redundancy (129). We therefore considered mean inter-
item correlations between 0.2 and 0.7 as satisfactory.  
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Convergent and divergent validity of the DISABKIDS questionnaire was assessed with 
reference to the CHQ-87 and CHQ-PF respectively using Pearson correlations adjusted for 
age and gender. A coefficient above 0.5 was considered high, between 0.3 and 0.5 as 
moderate convergence, while the measures were considered not to relate if the coefficient was 
lower than 0.3 (99;103). The DISABKIDS instruments’ discriminant validity was assessed by 
multiple regression analyses (103). 
Study 2  
The same procedures as described under study 1 were applied to calculate total scores on the 
DISABKIDS instruments, and results were reported as mean with one SD. Floor and ceiling 
values were reported as percentages. As appropriate, independent sample t-tests were used for 
continuous variables and chi-square tests for dichotomous variables when comparing 
background variables of participants and non-participants. Paired sample t-tests were applied 
to compare children’s/adolescents’ score with that of their respective parents. We used 
multiple regression analyses to assess the different factors thought to affect HRQOL among 
children and adolescents. Statistically significant findings have been reported as unadjusted 
and adjusted scores for each of the factors, with p-values in parenthesis.  
Study 3 
 In this study the main findings were based on qualitative methods, and primarily statistical 
methods were not found to be appropriate. However, we report briefly on statistical data in 
regard to participants: metabolic control was measured by HbA1c; the score on the System 
Usability Scale was calculated according to the manual; absolute score is reported, as is the 
statistical mean with SD. Scores on the theoretical knowledge tests were calculated manually. 
Pre and post results were compared by paired sample t-tests. SPSS version 18.0 (SPSS IBM, 
NY, USA) was used for all statistical analyses. 
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3.5. Qualitative analyses 
A semi-structured interview guide was developed (study 3) (Appendix 11), trying to elicit 
topics described in the aims of the pilot study. The guide emphasized questions regarding 
different experiences with the implemented technology. The interviews were recorded and 
then repeatedly listened to. Interviews were transcribed verbatim, and non-verbal aspects of 
the communication, like pauses and laughter, were included. Field notes based on mind maps 
were written during the interviews and used as an supplementary data source. Two different 
authors analysed and coded the texts. Main themes were extracted and interpretations, codes 
and themes discussed until consensus was reached (130).  
 
3.6. Ethical considerations 
All the children and adolescents and their parents gave written consent according to 
Norwegian requirements. All three studies were approved by the Regional Committee on 
Medical Research Ethics (Ref. 2009/773b). 
The collected paper-based data are stored in fire safes according to regulations. The 
anonymous scanned data are stored in the scientific database at Oslo University Hospital as 
appropriate. 
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4. Results  
4.1. Reliability and validity of the Norwegian child and parent versions of 
the DISABKIDS Chronic Generic Module (DCGM-37) and Diabetes-
Specific Module (DSM-10)  
The aim of the first study (paper 1) was to examine the reliability and validity of the 
Norwegian versions of the DCGM-37 and DDM-10 questionnaires when assessing HRQOL 
among children and adolescents with type 1 diabetes based on their own report and that of 
their parents. We conclude that the instruments are valid and reliable in a Norwegian 
population. 
Most scales in the Norwegian version had a Cronbach’s alpha similar to the European 
validation study, but the “Social inclusion” and the “Physical limitation” subscales had an 
alpha less than 0.7 in our material (Table 4). These findings are modified to only one scale, 
“Physical ability”, when using mean inter-item correlations. 
Further, our study reports convergent validity using the established HRQOL instruments, the 
CHQ-87 and CHQ-PF, respectively. Finally, we report that the DISABKIDS instruments have 
the ability to discriminate between groups, in a regression model, with significant differences 
in HRQOL score in relation to age and HbA1C. Higher age and increasing HbA1c were 
associated with lower HRQOL scale scores. We also found trends towards lower HRQOL 
among girls versus boys and of higher HRQOL among insulin pump users versus those on 
multi-injections. (The discussion of these results follows in chapter 5.) 
4.2. Health-Related Quality of Life among Norwegian children and 
adolescents on intensive insulin treatment. A population-based study   
The aims of the second study (article 2) were 1) to assess HRQOL among Norwegian children 
and adolescents with T1D in intensive therapy based on their own report and that of one of 
their parents by using the DCGM-37 and DDM-10, 2) to examine associations between 
32 
 
HRQOL scores and demographic and disease-related variables, and 3) due to the high 
percentage of intensively treated patients, to examine whether there are detectable differences 
in HRQOL scores between those on continuous subcutaneous insulin infusion and those on 
multiple daily injections (MDI).  
DCGM-37  
Mean self-reported DCGM-37 subscale scores were in the range 76 to 84, and the mean total 
score was 78 (SD=14). In a regression model we found that low DCGM-37 total scores and 
most subscale scores were significantly associated with high HbA1c, being a girl, and reports 
on DKA. We did not find a significant association between self-reported total score and 
different modes of insulin delivery in this intensively treated population. Parents’ total 
HRQOL score was lower than that of their offspring and this difference was considerable on 
the Social inclusion scale. Fathers’ scores were generally higher than those of mothers.  
DDM-10  
We found that low scores on the Impact and Treatment scales of the DDM-10 were associated 
with being a girl and high HbA1c values, while increasing age was associated with lower 
scores on the Treatment scale. We did not find any significant association between modes of 
insulin delivery or any of the DDM-10 scales. Parents scored lower than their offspring on 
Diabetes Acceptance, but higher on the Diabetes Treatment scale. (The discussion of these 
results follows in chapter 5. 
4.3. Improving diabetes care for young people with type 1 diabetes through 
visual learning on mobile phones: mixed-methods study. 
The third study (article 3) is a qualitative study, piloting two different mobile phone 
applications among adolescents with diabetes: a picture-based diabetes diary utilizing the 
camera in the mobile phone (Fig. 11) and an encrypted Internet-based Short Message System 
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(SMS) solution. Mixed methods were applied through measurement of HbA1c, theoretical 
knowledge tests and the SUS. 
 
Fig 11 Pictures reporting from a 24hrs registration. Pictures integrate food eaten, insulin 
dosages taken, pre and post glucose measurements and physical activity. Day 1 diagonal row 
and breakfast day 2 below. 
 
This study evaluated adolescent patients’ experiences with two different mobile phone 
applications used for diabetes care and examined whether an intervention using information 
and communication tools could affect level of knowledge and disease management measured 
by metabolic control, and through qualitative methods. Further, we wanted input to the 
product development as guidance for additional improvements of the applications. 
The most important finding of this study was the report of an educational part of the picture-
based diabetes diary. More than facilitating data collection and communication, all the 
informants reported a new and increased understanding of the cornerstones of diabetes 
treatment. The informants also reported that access to their doctor through an internet-based 
encrypted SMS solution gave  a feeling of security. They also gave important input to further 
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development of the applications. The use of triangulation of methods enabled the 
phenomenon to be viewed from many perspectives and supported the qualitative findings. 
However, no significant changes in HbA1c were found. (The discussion of these results 
follows in chapter 5.2.)
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5. Discussion 
5.1. Methodological considerations, quantitative methods 
 
The Internal validity of scientific works is basically the degree to which the conclusions 
drawn are correct based on the data available. External validity of scientific work deals with 
the inferences that can be drawn from the study setting to the outside world.  
In epidemiology, the connotation of this is to what degree the studied sample is representative 
of the total population. “Fundamentally, reliability concerns the extent to which an 
experiment, test or any measuring procedure yields the same results on repeated trials”(172, 
p11). In the following section, issues regarding the study design and threats towards internal 
and external validity, as well as the reliability issues, will be discussed. In relation to this we 
will particularly emphasize issues related to the use of questionnaires in population-based 
studies, such as: developmental and conceptual challenges, reliability and validity issues, self-
reporting, child and proxy reports, response bias and challenges with multicentre studies.  
The major strength of the quantitative parts of this thesis is the use of a population-based 
cross-sectional design. In paper one, we approached three different hospital cohorts and in 
study two we intended to approach the whole population of children and adolescents above 
eight with T1D in Norway. Further, we claim to have good data quality and through 
cooperation with NCDR we had detailed knowledge on major biomedical background factors 
for the non-participants as well as the participants. Population-based cross-sectional design 
has the ability to explore associations, but we did not aim to describe cause-effect relations 
between various aspects of T1D. Rather we searched for the diabetes population’s baseline 
scores on HRQOL instruments in order to fill in some of the missing parts of the intricate 
mosaics making up the picture of being young and living with T1D. The results created from 
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cross-sectional studies like the present ones further allow us to create hypotheses and test 
them in follow-up studies. It also adds strength to the study that we performed a qualitative 
study (study 3) as this approach has the ability to further deepen our understanding in regard 
to diabetes self-care.  
5.1.1. Development and conceptual issues 
A test instrument is not valid if the device does not measure what it intends to measure.  
Designing and developing instruments to be used in HRQOL studies is a complex process 
(98;99).  
Conceptually, the DISABKIDS instruments are based on the definition of HRQOL, including 
mental, social and physical components. Further they focus on the subjective evaluation of 
these components. The developmental process of the DISABKIDS instrument took into 
account the main critiques raised in HRQOL literature, the diversity in concepts and 
operationalizations as well as the multiplicity of test instruments applied in different studies 
making comparison across cultures and between studies and patient groups difficult (131). 
The DISABKIDS instruments seem, due to their design process, their underlying constructs, 
and our and earlier studies, to be valid and reliable enough to be applied on chronic disease 
groups. Nevertheless, relatively few studies using these instruments have been published so 
far. The EU-initiated project to develop cross-cultural instruments to measure HRQOL among 
children makes it possible to compare different patient groups and populations across Europe, 
making the instrument attractive to stakeholders and decision makers as well. However, as 
described in chapter 1.10., despite being developed across several European countries it is 
necessary to apply a thorough translation and validation process to such instruments to ensure 
their applicability in new populations. Study 1 reports on this procedure in the Norwegian 
population of T1D patients and their parents.  
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5.1.2. Reliability and validity of test instruments 
Measurement of HRQOL is a process that involves both empirical and theoretical 
considerations. The empirical focus is on the observable response, a cross in a tick box on an 
item in a self-report or an answer to a question. The theoretical concern is on the underlying 
concept meant to be measured. It is imperative to reliability and validity that the relation 
between the observed response and the underlying construct is strong. The HRQOL concept 
of the DISABKIDS group has been presented previously. Our validation study found strong 
internal reliability for most dimensions on the instruments. This confirms that the design 
process (98) and translation/validation procedure (article 1) have sufficiently addressed these 
issues, and that the response and the items are closely related to the constructs meant to be 
described.  
Cronbach’s alpha or “Inner consistency” is one of the most commonly used indicators of 
internal reliability and was used to estimate the reliability of the DISABKIDS instruments. 
The alpha assesses to what degree the items make up a scale or “hang together” (99;132). For 
group comparison an alpha of .7 or above is recommended. For short scales (less than 10 
items), low values are frequently found, and some researchers recommend reporting the inter-
item correlations and advise an optimal range for this of between .2 and .4 to avoid 
redundancy (i.e. that different items measure the same) (128). We therefore applied both these 
methods as reported (article 1).  
In study 1 we conclude that the  internal reliability for the DISABKIDS dimensions 
(subscales) are good except for the physical scale. However, most children with diabetes are 
not functionally disabled and this might explain why the inner reliability is low in regard to 
this scale. It is a weakness of our study that we did not apply factor analysis in study 1. In 
order to apply factor analyses, recommendations on sample size are at least 10 times the 
number of items in an instrument (99). The total number of participants at the three 
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contributing centres made such analyses inappropriate. Additionally, the study design did not 
allow for test-retest procedures, split halves or the alternative-form method to test reliability. 
However, the DCGM-37 showed high internal consistency reliability, as also reported in other 
studies (98). 
5.1.3. Validity of test instruments 
It is necessary to be especially aware of the content validity during the development of a test 
instrument. The conceptual definition of the constructs and the continuous review of the 
instrument to make it appear sensible were ensured through the initial developmental process 
with focus groups and field testing (97 p49). To ensure that the Norwegian edition covered 
the intended topics clearly and unambiguously, face validity was part of our translation 
procedure. A pilot study (not reported) was applied in a small group of young diabetes 
patients and their parents, and interviews were performed to judge the clarity, 
comprehensiveness and burden of the instrument and to ensure the applicability of the 
translated version.  
To assess construct validity of the DISABKIDS instrument, i.e. the extent to which a measure 
performs in accordance with theoretical expectation (99), we chose the most common 
approach: to compare the new instrument with an already valid and reliable HRQOL 
instrument (convergent validity). In our first study we therefore used the earlier validated and 
frequently used CHQ-87 and CHQ-PF. Further, we approached this by known group 
validation (divergent validity) and found that the DISABKIDS instruments are valid in a 
Norwegian population.  
In the second study, the DISABKIDS instruments were applied in a larger population but 
further validation procedures were not performed.  
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5.1.4. Self-reports 
Paper-based self-report questionnaires on HRQOL among children and adolescents might be 
seen as a limitation to our study. However, this method has the advantage that information 
from large samples can be collected in a standardized form. Further, we report parents’ data 
on the same variables in studies 1 and 2 and this adds credibility to the results. Historically it 
has been argued that children and young people lack the cognitive and linguistic skills to 
comprehend and respond to questionnaires (133). Further, it is argued that proxy ratings of 
HRQOL can provide important complementary information. On the other hand, it has been 
claimed that proxy reports could only be seen as substitutes for the children’s own ratings 
(133). Some researchers have shown that parents are more able to evaluate domains of 
physical functioning or symptoms and less capable when it comes to emotion and social 
functioning scales (134). The present consensus is that a self-report, also among children, is 
advocated (135). Nevertheless, due to discrepancies between children’s and parents’ reports in 
our study, we support the approach advocated by several researchers of obtaining information 
from both children and parents on HRQOL (133;136).  
Self-reporting is an easy and feasible way to collect data on large and geographically scattered 
populations. It gives the participants an opportunity to express subjective experiences, and it 
is supposed that the anonymity makes it easier to report on sensitive questions (137). 
However, it may be difficult to find participants and motivate them to fill in the 
questionnaires, and self-report is challenged by potential biases. Such potential errors that 
may have influenced our results are discussed later; nevertheless, what people report in 
studies like this has to be taken at face value (137). On the other hand, observer bias is not a 
problem in our and similar studies.  
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5.1.5. Children reports 
Due to children’s cognitive abilities, their self-reporting on HRQOL has been discussed 
(88;133). The need for HRQOL instruments that take into consideration different 
developmental phases for children and adolescents as they mature have been called for. One 
of the advantages of the DISABKID instruments, in relation to this, is the design process 
which included children and adolescents with chronic diseases in all phases of the 
developmental process (98;116). This ensures the adaptation to the developing child, and 
makes the self-report more valid in itself, especially among the youngest children. The 
DISABKIDS instruments are designed to be completed down to eight years of age, and the 
layout, as well as the relatively easy texts in the items, facilitates this approach (Appendix 
3,4).  
5.1.6. Parent proxy reports  
The advantage of proxy reports when measuring HRQOL in children and adolescents has 
been emphasized (133;138). It is important to bear in mind that in most studies of children 
with chronic diseases the parents report their child’s HRQOL as lower than the child themself. 
The reason for this might be due to a response shift, i.e. that people, in spite of an illness, 
express a positive view of their situation due to changes in internal standards, values and 
conceptualizations of their lives during the course of the disease (139). Studies 1 and 2 
confirmed earlier reports of lower scores on HRQOL from parents when than their childrens’ 
and adolescents’ scores. However, despite the statistically significant findings (study 2) of 
differences between children’s and parents’ scores, the magnitude of these differences was 
relatively low, indicating that the DISABKIDS instruments might be relatively well tailored 
to the children and that the parents’ scores actually reflect the patients’ perspective quite well. 
This may be an important finding as parents may rate the impact of filling in such 
questionnaires lower than their children and adolescents.  
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5.1.7. Internal and external validity 
The term “selection bias” mainly refers to the misrepresentation in regard to statistical 
analysis resulting from the method of collecting samples. If the selection bias is not taken into 
account, certain conclusions drawn may be wrong. The main concern in regard to internal 
validity in studies 1 and 2 is selection bias as the participation was voluntary and we report a 
moderate response rate in both studies 1 and 2. This bias may also be seen as a threat towards 
external validity ( i.e. the ability of the results to be generalized). However this is partly 
compensated for by the detailed knowledge on other characteristics among both participants 
and non-participants. Statistically we found significant differences between participants and 
non-participants in our study; vut when our team discussed these findings, e.g. in relation to 
metabolic control (HbA1c), the differences were so small that they were not considered 
clinically significant. In such assessments it is not only important to include mean values and 
SD, but also to compare the confidence intervals in order to evaluate the mean +- SD and 
assess this in a clinical context.  
Both of the DISABKIDS studies used paper-based questionnaires for data collection. Due to 
the population-based design and infrastructure-related factors involved in approaching all 
clinics treating young people with diabetes in Norway, we included a larger instrument panel 
than the DISABKIDS instruments,  in the adolescent group from 11 years and above as well 
as among the parents’ participants. The total amount of items in the instrument package for 
the parents and for adolescents aged 11 and above was high and this may have affected the 
response rate in our study. We also decided to leave it to the discretion of the participants 
whether to fill in the questionnaire at the hospital or at home. This might have influenced 
negatively the participation rate and may have affected the eventual selection bias. 
Nevertheless, this procedure was chosen due to the fact that most participants were expected 
to have long distances to travel, being dependent on public transport and having limited time 
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in the hospital clinics at each appointment. These were all factors thought to work against a 
high response rate. We considered allocating tablet computers with computer-based 
questionnaires at each outpatient clinic, but this was not possible due to time frame and 
copyright of the included instruments. These technologies are continually being approved and 
are recommended for future studies in our target population, as this also ensures direct 
notification of the response. Also, the total number of items in our questionnaires could have 
been lower. However, nearly half of the total eligible, and 55% of the approached population 
(see p.42) with T1D, participated. Compared to other population-based studies in Norway, 
this is as expected, and some have reported even poorer participation rates (140;141). We 
have considered this participation rate and argue that our knowledge on clinical variables 
among participants and non-participants rules out a substantial selection bias, minimizing the 
threat towards internal and external validity.  
5.1.8. Response bias 
Self-reporting questionnaires raise concerns about response bias or “a systematic tendency 
to respond to a range of questionnaire items on some basis other than the specific item 
content” (142). Response bias is a potential threat to the power and validity of the study.  
Response set is a strategy to apply the same response regardless of the question. One way to 
avoid response set is to mix negatively and positively worded items. Another technique is to 
keep the numbers of items low. The questionnaires in our study are constructed with a mix 
of positive and negative items. Further, our study applied a low number of items in the 
children questionnaire (n=47) (8-10 yrs), but can be criticized for the total number of items 
in the adolescent and parent questionnaires, as this may have contributed to a tendency 
towards a level of response set in our material.  
When assessing the results from our survey it is important to consider the theory of response 
shift, i.e. that an individual may change his or her internal standards, values and/or 
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conceptualizations on variables in his/her own life as a result of external factors such as a 
treatment or a change in health status (143). Chronically ill children have been found to 
score equal to or even better than healthy matches on different HRQOL instruments. 
However, the DISABKIDS instruments were developed in close cooperation with 
chronically ill children and adolescents, and seem to be well tailored to these young people’s 
values, thoughts and conceptualizations of the construct to be measured (98). In what way 
response shift may have affected the total results in our studies is uncertain, but our finding 
of non-significant changes associated with age and duration of disease respectively may be 
an indication of such shift among patients.  
 
A Likert scale is a psychometric scale commonly used in questionnaires. It consists of one 
or several Likert items ranging, for instance, from never, to always or completely disagree, 
to completely agree. In the DISABKIDS instruments the five-point Likert items are 
described by never, rarely, relatively often, very often and always and given numbers from 1 
to 5.  
It has been shown that children above eight years old accurately use a five-seven-point 
Likert item scale (144), and we therefore argue, in line with the developers, that the 
DISABKIDS instruments can be applied in our population from this age.  
Another criticism of these scales is that the Likert scale is based on ordinal data. An ordinal 
scale organizes the data in a particular order, but does not indicate a specific relationship 
between each item. This means that we cannot tell the distance between two points on the 
items; however, the statistical adaptation to such scales implies that they consist of sums 
across many items and therefore statistically can be treated as interval data (145).  
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In our studies we have applied parametric statistics; the appropriateness of this could be 
discussed. We appreciate that some of the continuous variables were not fully normally 
distributed, and categorical variables were slightly unbalanced, however parametric tests are 
robust and we argue, in line with others, that they tolerate minor violations of assumptions 
(146). We are also aware that some other DISABKIDS studies have found their material to 
be not normally distributed and applied non-parametric tests (119). Distributions of 
variables in our study were assessed by our group and the option of using non-parametric 
tests or transforming our variables was discussed. However, these tests also come with 
assumptions, and for large numbers parametric tests are recommended due to their 
robustness against non-normality (146-148). 
5.1.9. Participation and multicentre studies 
Twenty-seven centres treating young people with diabetes were invited to participate in our 
study, however two centres abstained from participation, and four centres did not complete 
the study correctly. This highlights the importance of thorough information for those closest 
to the participants and it also underlines some of the challenges of such large multicentre 
studies (149). However, we argue that due to the fact that the 21 participating centres were 
scattered all over the country, the high number of participants and the detailed knowledge on 
non-participants make it feasible to generalize the results to the whole population (Figure 12). 
  
Figure 12: Map of Norway presenting 
localization of all participating centres. 
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When calculating the response rate in our study we have used the total number of eligible 
children and adolescents at each centre. We asked each participating centre to report the exact 
number of patients not approached, if this for some reason happened. The participating 
centers reported that the reason that not all patients were approached was because of periods 
with large workload in the clinics; this, however, happened at random and therefore it did not 
introduce a bias. Due to the complexity of our study design and the substantial numbers of 
health-care personnel involved in these reports, only 14 centres reported this number; in 
addition, the data reported were considered suboptimal. In Figure 8 (p25) we have included 
the reports from these 14 centres, reducing the total number of eligible patients by 255. We 
are aware that these acquired data would have increased our participation rate to 55% (Figure 
8 p33) and therefore it is debatable whether our reports of 48% are too conservative.  
5.1.10. Conclusion, methodological considerations (study 1 and 2) 
In their report of one of the landmark studies on risk factors for cardiovascular disease, the 
research group states: “The phenomena we are reporting are those that have been observed 
to occur in Evans County. Much as we would like to generalize our findings to other men in 
the United States, we feel that this is not possible without replication” (150). This excellent 
testimony of limitations to statistical findings in relation to generalization is rarely reported. 
We are aware that the assumptions made to generalize our findings to a larger population 
may be disputed, but as we have argued throughout this text, the number of participants in 
our studies and the knowledge on several biomedical and socio-demographic variables 
among the participants and non-participants confirm that the two groups do not differ 
largely. We therefore argue that we can assume that the findings can be generalized to a 
larger population of young diabetes patients aged 8-11 in Norway. 
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5.2. Methodological considerations, qualitative method 
In study 3 we applied a multi-method design as this study used triangulation of methods to 
provide details of the observations that would not be obtainable by using only one method. 
However, the main focus in this study was to collect patients’ experiences through semi-
structured interviews, not to develop knowledge through quantitative methods. Nevertheless, 
all research has a limited validity if it is not successfully communicated (communicative 
validity) (130;151) the how in arguments, the why in consensus, and the who in regard to 
communication. Medicine has been closely associated with the positivistic scientific 
tradition where validity exists, and is thought to be the result and culmination of other 
empirical conceptions: i.e. universal laws, evidence, objectivity, truth, actuality, deduction, 
reason, fact and mathematical data (152). In order to communicate qualitative research to 
our own community we therefore also applied known methods like statistics in describing 
the participants and methods in our study. This adds strength to the communicative validity 
as the goal of all science is to create a sensible discussion on new topics.  
Qualitative research arising from a post-positivistic tradition is concerned with the meanings 
and experiences from the participants’ own perspectives in a project (130;152). To a large 
extent, the qualitative researcher embraces the involvement and role into the process, unlike 
the quantitative researcher who to a large extent attempts to dissociate themselves from the 
research process. In regard to the credibility of quantitative research, we have discussed, 
among other things, the construction of a test instrument, while in qualitative research the 
researcher is also the instrument. This implies that the credibility of qualitative research rests 
on the craftsmanship of the researcher(s) (153). Thus some state that reliability and validity 
in qualitative research are terms better described by other words like “credibility”, 
“transferability” and “trustworthiness” (154). However, if we return to communicative 
47 
 
validity, we don’t perform well as researchers if we introduce terms not related to the 
medical context and conceptions when we discuss qualitative methods. 
In an effort to reconceptualize reliability, validity and generalizability to be applicable in 
naturalistic research based on interviews, we therefore refer to Kvale, who says that the 
reliability and validity aspects need to be part of the craftsmanship of qualitative research in 
all its steps ( p165). The research steps are described in Table 5 and will be used as a 
skeleton for the methodological discussion.  
Thematization 
Design 
Interviewing 
Transcribing 
Analysing 
Verifying 
Reporting 
Table 5: Seven steps of qualitative research 
        (Kvale, p165(129)). 
 
5.2.1 Thematization and design of the study 
While working with young children with T1D, clinically and as an associated member of 
NCDR, we have gained knowledge about different aspects of the disease. Despite new 
innovative treatment options, collaboration between health-care personnel and strategies to 
support our patients, an improvement in treatment results is difficult to achieve (13). 
However, the collection of biomedical variables does not obtain data on the subjective 
experiences of our patients. In this study we have searched for adolescent patients’ 
experiences. Doing this, we have sought to contribute to new hypotheses for further research 
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on approaches that diabetes teams might apply to facilitate the use of young people’s 
competencies. For that purpose a descriptive qualitative study based on qualitative research 
and inspired by phenomenology and hermeneutics was designed. As the main author is 
trained as a medical doctor, the experiences gained through clinical work influenced the 
planning of the study. This might introduce a bias as the novel mobile phone applications 
were also designed and planned as a result of subjective appreciation of what young people 
would prefer. However, as one of the research questions was to describe patients’ 
experiences with two different mobile phone applications used for diabetes care, the design 
was founded on a patient as expert perspective. We therefore argue that this does not really 
introduce a validity problem to the study. 
The number of participants in a qualitative study needed to create enough data to ensure data 
saturation is a matter for discussion. In our study, 12 participants were enlisted, seven girls 
and five boys. Informed consent was obtained from all participants. Due to economic 
funding in our study and limitations in equipment, the Norwegian Centre for Telemedicine 
had the ability to deliver a maximum of 12 mobile phone/Bluetooth sets, and this gave the 
maximum number of participants in our study. However, we argue that the balanced 
representation of both genders and the variation in age of the participants, as well as their 
knowledge on mobile phones, represent the background population quite well. However, we 
are aware that our sample might be biased since it is not random. Those who responded may, 
for instance, be more technologically savvy, and we are careful not to generalize our 
findings to other populations. Nevertheless, in light of what Norwegian adolescents achieve 
in regard to treatment goals and the novel knowledge on brain development in modern 
neurobiology, the comprehension of our results seem logical and therefore transferable to 
the discourse on diabetes education and barriers to applied knowledge and action 
competences among our young patients. 
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5.2.2. Interviewing and data collection  
The reliability of the interviews depends on several steps. A semi-structured interview guide 
included questions to extract different experiences with the implemented technology.  Such 
interview technique may limit the data collection of the actual experiences in contrast to an 
more open interview where free association of experiences is sought for. However it also 
gives an advantage to the analyzes, because the same interview strategy has been used for all 
participants.   
It is imperative to reliability that the interviewer does not directly affect those interviewed 
and their answers. To avoid this bias we introduced an external researcher to perform 11 out 
of the 12 interviews. This was provided as the main author is also a clinical practitioner at 
one of the two outpatient clinics and we appreciated that this could influence the interview 
and data as participants could feel a pressure to respond in a certain way according to what 
they thought would be expected. The main author was present as an active observer at the 
interviews and was allowed to ask questions to deepen the concept if he felt this necessary. 
However, we are aware that  researchers may introduce biases through their active 
participation and this may have introduced a bias to the responses given by the participants. 
Nevertheless, this served an important data collection purpose as the main author took field 
notes on mind maps during the interviews and this also allowed him to observe the non-
verbal communication between the participant and the interviewer. 
The qualitative interview techniques are complex and we realized there was an ongoing 
improvement process taking place during our research process and that researchers in this 
matter can never be fully skilled. However, we aimed to ask open questions, to deepen the 
understanding of meanings and to recheck whether our comprehension of the phenomenon 
described was correct. Both researchers felt that the participants responded honestly to the 
questions and felt free to report both positive and negative experiences in the interviews.  
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In addition to collecting data from interviews, we also applied a written multiple-choice 
knowledge test (Appendix 9) and the System Usability Scale (described in article 3) 
(Appendix 10) as well as pre- and post-interventional HbA1c results. This methodological 
triangulation gave additional information and increased the reliability and validity of our 
results.   
5.2.3. Transcription 
Interviews were recorded and transcribed, including non-verbal communication such as 
laughter and pauses. All verbatim transcribed interviews were repeatedly listened to and 
nine out of 12 of the interviews were transcribed by the first author and 3 by external 
transcriber; this gave an overview of the whole material at the beginning of the analytical 
process. The interviews were transcribed verbatim in the various dialects spoken in the 
interviews and this made it difficult to use data programs in the analytical process. The 
weakness of verbatim transcription is that some statements can appear as incoherent and 
imprecise. Some therefore advocate using a slightly verbatim mode, but we did not apply in 
our study (155). Further, when translating into English (with the intention to publish in the 
Journal of Medical Internet Research) we strived to keep the content of the statements as 
close to the Norwegian meanings as possible. We are aware that this is a challenge to all 
qualitative researchers publishing in a language other than their native ones. However, the 
main rule should be to keep as close to the original wording and meaning as possible (151).  
5.2.4. Analyses and verification 
The analytic approach was based on qualitative description (156) as well as being influenced 
by phenomenology and hermeneutics (157). Analyses generated themes or codes from the 
data material. The analysis was conducted by the first author (DHF) and the last author (FS). 
As recommended, the developing analysis was discussed with the research team, and 
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continuously monitored by the last author (FS) to add credibility to the study and ensure 
agreement in main themes. This secured an external check of the research process whereby 
concepts and interpretations were challenged, discussed and reassessed. These procedures 
were applied to reduce the bias of one researcher being too involved in the topic, thereby 
affecting the results through researcher bias. We did not report the exact number of 
statements in each main theme; however, we are aware that this could have improved the 
transparency and reliability in the analysis. On the other hand, this could have introduced a 
positivistic reductionistic limitation to the analytical process.  
Our main theme, “visualization”, points to another functionality of the mobile application to 
what was initially intended: instead of being only an electronic diabetes diary designed to 
discuss insulin dosages and diet in the consultation, the participants reported that the 
Diamob application increased their understanding of cornerstones in diabetes treatment. The 
interpretation of this in relation to reliability is that we throughout our analyses were open to 
the data material and that as researchers we were guided by the responses from participants 
rather than by our preconceptions.  
5.2.5. Conclusion, methodological issues (study 3) 
As previously mentioned, communicative validity is important in all science (130). If we try 
to demystify the term “validation” we can quote Finn Skårderud when he states that “To 
validate is to convince the critical reader that the research results are direct and probable 
consequences of the research process itself, and not more or less random statements” (153). 
In this presentation I have sought to communicate to the critical reader that the reliability 
and validity of qualitative research have been a continuous imperative throughout the 
process and that our craftsmanship as researchers has provided trustworthy results.  
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6. General discussion, clinical and research implications  
 
This study focuses on HRQOL, measured through patients own reports, as an outcome 
variable thought to be important for the daily self care of people living with diabetes. It also 
reports on a pilot study indicating that the use of information and communication tools in 
teaching diabetes self-management to young people might be important. Future research into 
options optimized to increase patients’ applied competences, coping and self-care are 
important in order to shed light on how to improve health-care strategies and treatment 
results.  
In our first study we report on the psychometric properties of the DISABKIDS instruments. 
As already mentioned, the use of HRQOL instruments on a routine basis in the follow-up of 
children and adolescents with diabetes is, to our knowledge, non-existent in Norway. 
Previous research has documented that the use of such instruments facilitates the process of 
discussing psychosocial factors, results in more satisfied users, and also makes it easier to 
uncover those in need of referral to other health-care providers (50;158;159). It is therefore 
important to find relatively brief, valid and reliable questionnaires in daily practice (160). 
The fact that the DISABKIDS instruments fulfil these criteria and are available as computer 
programs and can be completed by the patient and automatically scored prior to consultation 
make them particularly attractive in clinical practice (161). The Norwegian Childhood 
Diabetes Registry includes a benchmarking process, where quality variables are 
standardized and compared between the paediatric clinics, and discussed in annual reports 
and collaborative meetings (59). In diabetes care it is well documented that the use of annual 
reports improves the examination of patients and also has the potential to improve outcome 
(162;163). A slight reduction in the frequency of severe hypoglycaemia has been reported, 
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but only a minor improvement in HbA1c has been achieved in spite of 11 years of annual 
benchmarking of biomedical variables in Norway. We therefore suggest that the time has 
come to implement patient-reported outcomes, such as HRQOL measurements, as one of the 
benchmarking variables. Further, international recommendations advocate such screening 
tools to be used in clinical work in order to uncover psychosocial factors that might affect 
daily self-treatment. The DISABKIDS instruments are relatively brief, culturally and age 
appropriate for a wide age group, and simple to use. Our findings in study 1 show that the 
instruments are applicable in the Norwegian diabetes population and this opens up for 
comparison between different European populations. In reviews of HRQOL studies, the lack 
of similarity both in instruments and populations is frequently discussed as a challenge in 
order to compare different studies. Standardized European instruments like DISABKIDS 
and its sister project KIDSCREEN are therefore important. The DISABKIDS instruments 
seem to be well adapted to children’s and parents’ perspectives, but prospective longitudinal 
studies are needed to prove the applicability of these instruments in clinical work. We do not 
state that the DISABKIDS HRQOL instruments are superior to other screening tools; in line 
with others we rather suggest a broad approach as early as possible after diagnosis. 
However, the cross-cultural development of these instruments and the age appropriateness, 
earlier reported, make them highly preferable for comparable studies across patient groups 
and nations (98).  
Our second nationwide study is the first larger epidemiological study of the Norwegian child 
and adolescent population in regard to HRQOL. The significant associations between lower 
HRQOL score, and poor metabolic control (HbA1c), being a girl and occurrence of one 
DKA , highlights that HRQOL seems to be one of the components associated with improved 
self-treatment and metabolic control. Clinicians should also be aware of the strong 
association between DKA and poor HRQOL. “Psychosocial factors are the most important 
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influence affecting the care and management of diabetes” (quoted in Delamater, 2009, 52 
p175). Despite the awareness of psychosocial issues in T1D, current practice indicates that 
young people that exhibit clinical levels of maladjustment and distress are not diagnosed or 
referred for treatment (164) (unpublished reports NCDR). Studies have shown that 
paediatricians under-identify psychosocial problems (50;158). Paediatricians are found to be 
highly specific, i.e. identifying correctly those without behavioural or emotional problems 
but with low sensitivity, i.e. identifying only 17% of those with such problems (50). It is 
well documented that implementing routine screening of HRQOL improves patient 
satisfaction with care and psychosocial well-being (52;159;165). The use of HRQOL 
instruments among children and adolescents in research and clinics has been advocated 
(52;166). ISPAD and ADA have implemented this in their guidelines for best practice (51). 
In spite of this, most paediatric centres working with children and adolescents with diabetes 
in Norway do not have psychologists or social workers in their teams. Further, there are no 
centres doing routine-based screening of HRQOL parameters, and it is not implemented as 
an outcome in the annual routine screening of this patient group in relation to benchmarking 
through the NCDR.  
Our results show that although the children on average score similarly to other European 
populations on the generic instrument, they score substantially differently on the diabetes-
specific instrument. The finding of a poor score on the DDM-10 dimension related to 
treatment itself indicates that this should, to a large extent, be the focus of the consultations 
among our child and adolescent population.  We also conclude that the different modalities 
of intensive insulin treatment, i.e. insulin pump versus insulin pens, are unrelated to HRQOL 
score. However, the burden of carrying the equipment and planning the treatment seems to 
be perceived more negatively in the Norwegian population than in comparable populations.  
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Psychosocial factors identified at diabetes diagnosis predict later psychological 
complications, non adherent behaviour and poor metabolic control (40;167). The burden of 
diabetes among young people with diabetes is well documented. Adolescents with diabetes 
rated their HRQOL lower than healthy subjects and also lower than adolescents diagnosed 
with cystic fibrosis, inflammatory bowel disease, epilepsy and post-renal transplantation, 
when HRQOL was measured among adolescents with eight different chronic conditions 
(168).  
Reports and recommendations highlight the importance of early screening and diagnosis and 
referral to increased care and support in order to improve outcome (40;51). However, a 
numbers of barriers (i.e. family factors and aspects of the health-care system) seem to exist 
before implementing this (30;40;158;167;167). A recent publication on practical advice on 
the implementation of such strategies includes the combination of semi-structured interviews 
with one or more screening tool(s) applied by staff trained in behavioural health (167). This 
underscores the importance of multidisciplinary diabetes teams.  Further, De Wit et al. was 
the first to document improved results among young people with T1D by measuring and 
discussing HRQOL (159). The same group later documented the importance of follow-up on 
these variables in order to achieve a lasting effect (53;159). Further studies on background 
factors to explain why Norwegian children score higher on the DDM-10 Acceptance 
(Impact) scale and lower on the Treatment scale might shed light on obstacles related to 
poor metabolic treatment results.  
 
Our finding of a significant association between higher HbA1c and lower HRQOL and 
relatively low achievement of treatment goals should stimulate further research, to evaluate 
strategies hypothesized to facilitate the utilization of learned skills and knowledge into 
applied competences with both biomedical and patient-reported outcome measurers.  
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In line with international recommendations, we also advocate that diabetes teams find 
standardized patient-reported outcome measures in order to uncover early those in need of 
increased support, and also to follow such outcome measures on a longitudinal basis.  
 
Self-management of T1D is highly dependent on research into aspects that relate to diabetes 
self-management education. The last 20 years of diabetes education has been affected by an 
increased emphasis on integrated educational strategies, and collaboration with the patient 
(169;170). The findings from our study (study 3) indicate that visualization of the 
cornerstones of diabetes self-management, i.e. physical activity, food intake, insulin doses and 
glucose measurements, seems to improve the applied competences in daily diabetes 
management. This study suggests that the young people living with T1D, despite having 
theoretical knowledge, report fragmented understanding of their self-treatment and struggle 
with the implementation of these fragments into applied competences. It has been shown that 
visual tools designed by young people in their personal settings seem important for 
developing patients’ comprehension, recall and adherence (71;72). It is possible that the 
Diamob stimulates reflection in action and facilitates comprehension of patients’ own self-
treatment. It is likely that this strategy of learning by doing is particularly well suited to young 
people, as they often oppose correction from others. Our research team hypothesizes that this 
finding may be related to neurobiology and the continuous development of the brain. Novel 
longitudinal studies using magnetic resonance imaging (MRI) have provided evidence on the 
ongoing maturation of the frontal cortex into adulthood (69;70). To perform well in self-care, 
the patients depend on well-developed executive functions, the abilities to store important 
information and holding in mind a plan to carry out in the future and inhibit impulses. Work 
on animals and humans has associated these behaviours with the frontal lobes maturing late in 
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the adolescent period (70). MRI studies have shown that maturation of the visual cortex and 
successive pruning of neural contact happen early in childhood compared with the frontal 
parts of the brain where the centres for cognitive functions like planning and advanced 
thinking are localized (69;70). The relatively poor treatment results among young people with 
diabetes challenge us to continuously review our clinical methods and implementation of new 
strategies to stimulate increased competence and coping among our patients. Further studies 
on strategies in diabetes treatment utilizing and facilitating eHealth are advocated as we will 
need to adapt to a new generation of young people who are used to exploiting such tools in 
daily life and view it as a necessity of their life. New strategies like the ones used in this study 
(study 3) need to be tested in larger randomized controlled studies to evaluate the effects. 
7. Implications for future research 
 
The current study examined associations between HRQOL mode of treatment and treatment 
outcomes in a cross-sectional study. Whether interventions with the goal of improving 
HRQOL or whether routine assessments of HRQOL improve coping and metabolic control 
were not answered and need to be addressed in proper intervention studies, preferably 
randomized control studies.  We also advocate including HRQOL results in addition to the 
traditional biophysical parameters in clinical trials.  
 
Further research into the associations between self reported HRQOL and other outcome 
variables to investigate their associations and interactions is important and also has the 
potential to widen our knowledge on such psychosocial factors and their role for patients’ 
coping and treatment results. Studies using instruments that targets more specific 
psychosocial factors like eating disorders, fear of hypoglycemia, problem areas in diabetes 
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and family related factors in association to children and adolescent with T1D is 
recommended.  
 
Longitudinal studies that document HRQOL in the child and adolescent diabetes population 
as well as implications for HRQOL later in life is suggested. This can be facilitated by 
including such screening in the ongoing benchmarking in NCDR.  Further collaboration 
across nations and with different patient populations with a standardised instrument make us 
able to do comparative studies. Such studies across patients and nations will also serve as a 
response to the criticism on lack of similarity between HRQOL studies.   
 
The pilot study of using mobile phone applications in the management of the disease, points 
towards interesting new avenues of follow-up. Whether such new technologies represent new 
meaningful ways of follow-up or how such applications best can be utilized also need to be 
addressed in randomized control studies where applied knowledge, competences and coping 
in addition to metabolic control and HRQOL  are meaningful outcome variables.  
Future studies on brain development and function may also be important to understand further 
educational strategies towards the child and adolescent patient populations.  
 
The authors highlight the importance of epidemiological, quantitative studies of the total 
Norwegian population of young people living with diabetes.  In order to get wider pictures 
and uncover the private, often complex reasons behind treatment challenges we also suggest 
studies using qualitative methods. This thesis therefore suggests that research into new 
strategies that might have positive implications for diabetes self-management education and 
self-treatment needs to be tested out in studies using mixed methods. As researchers we will 
need a variety of methods at our fingertips if we are to understand the complexity of modern 
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systems (171). We need to be trained in more than one scientific method and be able to utilize 
the complementarities. 
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Spørreskjema om barns helse - CHQ - CF 87 
Til barn og ungdom 
 
1. Vi vil gjerne spørre om hvordan du har det, hvordan du føler deg og aktiviteter du gjør hver 
dag. Dine svar vil ikke bli vist til andre. 
2. Deltagelsen er frivillig. 
3. Du svarer ved sette  kryss i en av rutene  (                         ). 
4. Selv om enkelte spørsmål kan se like ut, er det viktig at du svarer på alle spørsmålene. 
5. Det finnes ingen riktige eller gale svar. 
 
 
 
Del#1:Generell helse 
 
1.1. Stort sett, vil du si at din helse er: 
Utmerket Meget god God Ganske god Dårlig 
 
 
 
Del#2: Fysisk aktivitet 
 
2.1. I løpet av de siste 4 ukene , har det vært vanskelig for deg å gjøre noen av de følgende 
aktiviteter på grunn av helseproblemer?   
  Ja, svært 
vanskelig 
Ja, ganske 
vanskelig 
Ja, litt 
vanskelig 
Nei, ikke 
vanskelig 
a. gjøre ting som krever mye anstrengelse  
som å spille  fotball , løpe eller gå på tur? 
    
b. gjøre ting som krever ganske mye 
anstrengelse, som å sykle eller gå på 
skøyter? 
    
c. gå  langt eller gå opp flere trapper?     
d gå rundt i nabolaget, til lekeområde eller      
til  skolen? 
    
e. gå ett kort stykke eller gå opp en trapp?     
f. hjelpe til hjemme?     
g. sitte på huk, løfte noe eller bøye deg?     
h. spise, kle på deg, bade eller gå på     
toalettet alene? 
    
i. komme deg opp i og ut av sengen?     
Appendix 7: CHQ-87 questionnaire 
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Del#3: Daglige aktiviteter 
 
3.1. Har det, i løpet av de siste 4 ukene,  vært vanskelig for deg å gjøre skolearbeid eller 
delta i vanlige aktiviteter med venner fordi du har følt deg TRIST eller ENGSTELIG? 
                                                            
Har det vært vanskelig å: 
Ja, svært 
vanskelig 
Ja, ganske 
vanskelig 
Ja, litt 
vanskelig 
Nei, ikke 
vanskelig 
a. gjøre visse TYPER skolearbeid eller 
aktiviteter med venner 
    
b. bruke like MYE tid som du pleier på 
skolearbeid eller aktiviteter med 
venner 
    
c. GJØRE skolearbeid eller  delta i 
aktiviteter med venner i det hele tatt 
    
 
3.2. Har det, i løpet av de siste 4 ukene, vært vanskelig for deg å utføre skolearbeid eller 
vanlige aktiviteter med venner på grunn av problemer med din OPPFØRSEL? 
                                                            
Har det vært vanskelig å: 
Ja, svært 
vanskelig 
Ja, ganske 
vanskelig 
Ja, litt 
vanskelig 
Nei, ikke 
vanskelig 
a. gjøre visse TYPER skolearbeid  
eller aktiviteter med venner 
    
b. bruke like MYE tid som du pleier   
på skolearbeid eller aktiviteter   med 
venner 
    
c. GJØRE skolearbeid eller  delta i 
aktiviteter med venner i det hele  
tatt 
    
 
3.3. Har det, i løpet av de siste 4 ukene,  vært vanskelig for deg å utføre skolearbeid eller 
vanlige aktiviteter med venner på grunn av problemer med din FYSISKE helse? 
 
                                                            
Har det vært vanskelig å: 
Ja, svært 
vanskelig 
Ja, ganske 
vanskelig 
Ja, litt 
vanskelig 
Nei, ikke 
vanskelig 
a. gjøre visse TYPER skolearbeid  
eller aktiviteter med venner? 
    
b. bruke like MYE tid som du pleier   
på skolearbeid eller aktiviteter    
med venner? 
    
c. GJØRE skolearbeid eller  delta i 
aktiviteter med venner i det hele 
tatt? 
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Del#4: Om å ha vondt 
 
4.1. I løpet av de siste 4 ukene, hvor mye vondt eller hvor sterke smerter har du hatt? 
 
 
Ingen Meget svake Svake Moderate Sterke Svært sterke 
 
4.2. I løpet av de siste 4 ukene, hvor ofte har du hatt smerter eller vondt? 
 
 
Aldri En eller to      
ganger 
Noen få  
 ganger 
Ganske ofte Meget ofte Hver dag 
eller nesten 
hver dag 
 
Del#5: Om deg selv 
 
5.1. I løpet av de siste 4 ukene, hvor ofte kunne hver av de følgende uttalelser beskrive deg? 
  Svært 
ofte 
Ganske 
ofte 
Noen 
ganger 
Nesten 
aldri 
Aldri 
a. oppført deg barnslig?      
b. kranglet?      
c. hatt vanskelig for å konsentrere 
deg? 
     
d. latt være å gjøre som læreren eller 
foreldrene dine har bedt deg om? 
     
e. villet være alene?      
f. løyet eller jukset?      
g. hatt problemer med å bli likt?      
h. følt deg klønete?      
i. rømt hjemmefra?      
j. hatt talevansker (f.eks. stamming)?      
k. stjålet noe hjemme?      
l. stjålet noe borte?      
m. blitt  sur hvis du ikke har fått det 
som du ville? 
     
n. blitt skikkelig sint hvis du ikke har 
fått det som du ville? 
     
o. syntes det har vært vanskelig å 
være sammen med andre? 
     
p. syntes det har vært vanskelig å 
være venner? 
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5.2. Sammenliknet med andre barn på din alder, vil du si at din oppførsel  er: 
 
Utmerket Meget god God Ganske god Dårlig 
 
 
 
Del#6: Følelser og humør 
 
6.1. I løpet av de siste fire ukene, hvor stor del av tiden har du: 
  Hele 
tiden 
Nesten 
hele 
tiden 
En del 
av tiden 
Litt av 
tiden 
Ikke i 
det hele 
tatt 
a. følt deg trist?      
b. hatt lyst til å gråte?      
c. følt deg redd eller skremt?      
d. bekymret deg for ting?      
e. følt deg ensom?      
f. vært ulykkelig?      
g. vært nervøs?      
h. følt deg irritert eller sint?      
i. vært glad?      
j. vært i godt humør?      
k. trivdes med det du gjør?      
l. hatt det morsomt?      
m. følt deg rastløs?      
n. hatt problemer med å sove?      
o. hatt hodepine?      
p. likt deg selv?      
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Del#7: Selvtillit 
 
7.1. I løpet av de siste 4 ukene, hvor fornøyd har du vært med: 
  Svært 
fornøyd 
Ganske 
fornøyd 
Hverken 
fornøyd eller 
misfornøyd 
Nokså 
mis-
fornøyd 
Svært 
mis-
fornøyd 
a. deg selv?      
b. skolearbeidet ditt?      
c. hvor flink du er i idrett?      
d. vennene dine?      
e. de tingene du KAN?      
f. hvordan du kommer overens 
med andre? 
     
g. kroppen  og utseendet ditt?      
h. hvordan du stort sett føler 
deg? 
     
i. hvordan du kommer overens 
med familien? 
     
j. livet ditt?      
k. deg selv som venn?      
l. hva andre synes om deg?      
m. hvor flink du er til å snakke 
med andre? 
     
n. helsen din?      
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Seksjon#8: Helse 
 
8.1. Hvor riktig eller gal er hver av de følgende påstander for deg? 
  Helt 
riktig 
Delvis 
riktig 
Vet 
ikke 
Delvis 
gal 
Helt 
gal 
a. Min helse er utmerket.      
b. En gang var jeg så syk at jeg trodde 
jeg  skulle dø. 
     
c. Jeg pleier ikke ut å bli så veldig syk.      
d. Jeg tror ikke jeg er like frisk som 
andre barn jeg kjenner. 
     
e. Jeg har aldri vært veldig syk      
f. Jeg blir alltid syk.      
g.  Jeg tror jeg kommer til å få dårligere 
helse når jeg blir eldre. 
     
h. Jeg tror jeg kommer til å ha veldig 
god helse når jeg blir eldre. 
     
i. Jeg bekymrer meg aldri om helsen 
min. 
     
j. Jeg føler meg frisk nå.      
k. Jeg tror jeg bekymrer meg mer for 
min helse enn andre på min alder. 
     
 
 
 
 
 
8.2. Sammenliknet med for ett år siden, hvordan vil du vurdere helsen din nå: 
 
 
 
Mye bedre nå 
enn for 1 år 
siden 
Litt bedre nå 
enn for 1 år 
siden 
Omtrent den 
samme nå som 
for 1 år siden 
Litt dårligere nå 
enn for 1 år 
siden 
Mye dårligere 
nå enn for 1 år 
siden 
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Del#9: Familien 
 
9.1. I løpet av de siste 4 ukene, hvor ofte har din helse eller atferd: 
 
  Svært 
ofte 
Ganske 
ofte 
Noen 
ganger 
Nesten 
aldri 
Aldri 
a. begrenset de aktivitetene familien 
kunne gjøre sommen? 
     
b. avbrutt forskjellige daglige  familie 
aktiviteter (måltider, se på TV)? 
     
c. begrenset familiens muligheter til å 
gjøre noe på kort varsel? 
     
d. ført til spenning eller konflikter i 
hjemmet? 
     
e. vært en årsak til uenighet eller 
krangling i familien? 
     
f. gjort at familien har måttet forandre 
eller avlyse planer i siste liten? 
     
 
9.2. Iblant har familier problemer med å fungere sammen. De er ikke alltid enige og de kan 
bli sinte på hverandre. Stort sett, hvordan vil du vurdere din families evne til å fungere 
sammen? 
 
Utmerket Meget god God Nokså god Dårlig 
 
 
 
Del#10:  Om deg selv 
 
 10.1. er du 
 
 
Gutt Jente 
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10.4. Har du noen gang søkt hjelp hos noen på skolen, helsestasjon eller legekontor for? 
(Kryss av for Ja eller Nei ved hvert spørsmål)   
 Ja Nei 
a. Skader som følge av ulykker? •   •  
b. Sengevæting? •   •  
c. Brystsmerter? •   •  
d. Diare eller forstoppelse? •   •  
e. Langvarig  slapphet? •   •  
f. Hodepine? •   •  
g. Dårlig matlyst over tid? •   •   
h. Mareritt eller søvnproblemer? •   •  
i.  Magesmerter? •   •  
 
 
 
TAKK FOR AT DU SVARTE PÅ SPØRSMÅLENE! 
Appendix 8: CHQ-Parent form 50 
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SPØRREQUIZ 
Diabetesbehandlingen stiller store krav til den som lever meddiabetes. Noen ganger er det lurt å 
repetere litt om hva diabetes er. Fyll ut spørreskjemaet og svar det du mener er riktig 
 
1:Det finnes to typer diabetes. Type 1 er den som flest ungdom har. Type 1 diabetes skyldes… 
At man har spist for mye sukker da man var mindre   
At man er overvektig og insulin virker dårligere i kroppen. 
At cellene i bukspyttkjertelen ikke lenger produserer nok insulin  
 
2: Blodsukker er mengden glukose i blod. Normalt blodsukker varierer mellom… 
0-3  
4-8 
6-10  
 
3: Når du går til kontroll på poliklinikken måles HbA1c. Hva er HbA1c? 
Den sier noe om hvor høyt blodsukkeret har vært siste 3-4 uker  
Den sier noe om hvor høyt blodsukkeret har vært i gjennomsnitt de siste 2-3 månedene 
Den forteller hvor mange doser insulin jeg har satt siden jeg var hos legen sist. 
 
4: Lavt blodsukker kalles hypoglykemi. Symptomer på dette kalles føling. De fleste tar 
druesukkertabletter hvis de får føling( det er lurt å måle blodsukkeret først) Hvilket utsagn under 
synes du stemmer best? 
 Man bør alltid ta druesukker hvis blodsukkeret er under 6 
Man bør ikke ta druesukker før blosukkeret er under 2 
På dagtid er det greit å vente på neste vanlige måltid hvis blodsukkeret er rundt 4  
 
5: Føling kan være ubehagelig. Mange tror føling er svært farlig. Hva mener du er riktig av utsagnene 
under? 
Det er bedre for kroppen å unngå føling og at man forsøker å ha et blodsukker mellom 9 og 15  
Det er best for kroppen at man ligger lavt i blodsukker og ofte måler blodsukker mellom 2 og 4 
Det er best for kroppen at man verken har mange høye eller mange lave blodsukkerverdier. 
 
6: Høyt blodsukker over tid.. 
kan man lett merke på kroppen at man har  
er lurt å ha fordi man unngår alvorlige følinger 
kan gi akutte plager, men også komplikasjoner senere i livet  
 
Appendix 9: Knowledge test, qualitative study 
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7: Druesukkertabletter inneholder karbohydrat. Hvilken vekt har du og hvor mange tabletter eller 
hvor mange gram karbohydrat tar du hvis du har føling? 
Jeg er   ___________KG .  Jeg tar _____tabletter av typen____________ når jeg har føling.     
Jeg tar ________gram karbohydrat for å heve blodsukkeret med ca 2 enheter når jeg har føling 
 
8: Hva er glukagon? 
Et motreguleringshormon som kroppen selv produserer hvis man får veldig lavt blodsukker. 
Et stoff som diabetikere bør spise ofte. 
Glukagon er akkurat som Insulin og virker slik at blodsukkeret synker. 
 
9: Når du har blodsukker over 15 kan det være lurt å måle ketoner. Hvilket utsagn er mest riktig. 
Det gjør ingen ting om jeg har ketoner over 4  
Ketoner i blodet betyr at jeg har fått for lite insulin over tid og at kroppen bryter ned fett som 
      energi til cellene. 
Ketoner i blodet betyr at jeg har spist for mye sukker  
 
10: For lite insulin til maten jeg spiser fører til..  
At maten ikke blir fordøyd ordentlig  
 Lavt blodsukker og føling 
At jeg får høyt blodsukker   
 
11: Novo Rapid er et hurtigvirkende insulin som mange bruker i pumpe eller penn. 
Novo Rapid har sin maksimale virkning etter ca 1 time og det passer med  
       blodsukkerstigningen etter et måltid. 
 Novo Rapid skal settes ca 2 timer etter måltid, hver gang. 
Det er bedre å bruke langtidsvirkende insulin (Insulatard )når man skal spise. 
 
12: I puberteten skjer det masse med kroppen. For de som har diabetes endrer også mye seg. Hvilket 
utsagn under er mest korrekt? 
Man trenger mindre insulin enn man gjorde før man gikk inn i puberteten 
Man får ofte større insulinbehov når man er i pubertet, spesielt om natten  
Puberteten fører til mer hormoner. Slik at kroppen også produserer mer av hormonet Insulin  
      enn før puberteten. 
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13: Hvilken av disse uttalelsene om karbohydrater er feil? 
Karbohydrater finnes bare i sukker. 
Karbohydrater gir kroppen energi. 
Karbohydrater bør utgjøre omtrent halvparten av vårt daglige energiinntak. 
Karbohydrater øker blodsukkeret. 
14: Det anbefales at vi spiser nesten halvparten av energien vår som karbohydrater.  Hvilken av 
matvarene under er det lurt å spise mer av? Kryss av for det riktigste svaret. 
Korn, poteter, ris, pasta 
 
Karbohydrater fra brød og fiber                  
 Sukkerholdige matvarer 
15: Hvilken av disse faktaopplysningen om juice er riktig? 
Juice inneholder masse fett 
Juice inneholder veldig lite sukker  
Juice er en god proteinkilde 
Det er nesten dobbelt så mye sukker i 1 glass juice som i 1 glass melk 
16: Alternativene under er råd for et godt kosthold, men ett råd er dårlig,hvilket? 
Spis relativt lite fett 
Unngå mettet/animalsk fett 
Drikk mer vann 
Drikk helmelk  
Spis mer fiberrik mat 
17: Hvis du har diabetes, hvilket nivå bør blodsukkeret ligge på ved måling  2 timer etter middag? 
2-4 mmol/L 
4-10 mmol/L 
10-14 mmol/L 
Høyere enn 14 mmol/L 
 
 
 160 
 
 
 18: Hva er forskjellen på type 1 og type 2-diabetes? 
Type 1-diabetes er forstadiet til type 2-diabetes 
Type 1-diabetes debuterer ofte hos barn Type 2-diabetes debuterer som regel hos godt voksne  
Insulin er standardbehandlingen ved type 2, men ikke ved type 1-diabetes 
Type 1-diabetes skyldes insulinmangel, mens type 2-diabetes skyldes insulinoverskudd  
19: Hva er hovedoppgavene til hormonet insulin? 
Å senke blodsukkeret  
Å heve blodsukkeret  
Å øke frigivingen av sukker fra leveren 
Å øke utskillelsen av sukker fra musklene 
20: Hvordan oppdages diabetes vanligvis? 
Det måles et for lavt blodsukker 
Det foreligger "føling" + at blodsukkeret måles for lavt 
Det foreligger symptomer på høyt blodsukker tørste, økt mengde tissing, slapphet. 
Det måles for høyt blodsukker 
 
21: Hvilke av følgende komplikasjoner er ikke typisk for diabetes? 
Åreforkalkning (arteriosklerose) 
Lavt blodsukker (hypoglykemi) 
Høyt blodsukker (hyperglykemi) 
Hard avføring 
22: Hva er ikke en vanlig årsak til lavt blodsukker?  
For mye insulin                    Dårlig regulert diabetes med store reperasjonsdoser 
Fysisk aktivitet                     Glemt dose med insulin 
23: Hva er det vanligste problemet ved diabetes? 
At blodsukkeret er for høyt 
At blodsukkeret er for lavt 
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24: Hva er et bra (ikke-fastende) blodsukker? 
4-10 mmol/L 
10-14 mmol/L 
14-18 mmol/L 
Over 18 mmol/L 
25: Hvilken matsort nevnt nedenfor er gunstigst for blosukkerreguleringen din?  
Poteter 
Pasta 
Småkaker 
Kornblanding 
26: Er regelmessig mosjon bra for behandlingen av diabetes? 
Ja 
Nei, man bør ta det med ro 
Nei, blodsukkeret stiger ved mosjon 
Nei, det øker risikoen for "føling" 
27: Hvis du regelmessig kontrollerer ditt blodsukker, når skal du da teste deg? 
2 timer før måltid 
30 minutter etter måltid 
1,5 timer etter måltid
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System Usability Scale (SUS)  
© Digital Equipment Corporation, 1986. 
Norwegian version (translated by Eirik Årsand) 
 
         Helt            Helt 
         uenig            enig 
 
1. Jeg kunne tenke meg å bruke dette  
     systemet ofte  
 
2. Jeg synes systemet er unødvendig 
    komplisert 
 
 
3. Jeg synes systemet er enkelt å bruke 
 
 
 
4. Jeg skulle gjerne hatt teknisk hjelp for  
    å være i stand til å bruke systemet 
 
 
5. Jeg synes de ulike delene i 
     systemet henger fint i sammen 
 
 
6. Jeg synes det var for mye  
    uoverensstemmelse mellom de ulike 
    delene i systemet 
 
7. Jeg vil tro at de fleste vil kunne lære 
    seg dette systemet veldig raskt 
 
8. Jeg synes dette systemet er veldig 
    tungvint å bruke 
 
 
9. Jeg føler at jeg mestrer dette systemet 
    veldig bra 
 
 
10. Jeg trenger å lære meg mange flere 
      ting før jeg kan komme i gang med å  
      bruke systemet 
 
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5  
Appendix 10: System Usability Scale 
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Intervjuguide  
START:  
  
Hvorfor vil jeg snakke med deg? 
 
Hvor lang tid vil det ta?  
 
Anonymt.  
SELVE INTERVJUET: 
 
Tredelt - studie:  
1. SMS inn 
2. SMS ut 
3. Diadagboka 
FØR PROSJEKTET 
1. Diabetessykdommen - livet med?Empowerment,  Kompetanse, mestring og 
egenomsorg 
 Fortell litt om livet ditt som diabetiker. Sammenheng mellom sykdommen du 
har og livet du lever? 
 Fortell hva du opplever som mest utfordrende i ditt liv med daibetes? 
 Hvorfor opplever du dette som mest utfordrende? 
 Fortell hvordan du opplevelr mestring – herunder tilgang til kunnskaper, 
sosiale ressurser eller utstyr, og evne til å utnytte disse.  
 Kompetanse: Hva forbinder du med ordet kompetanse og kompetanse i 
relasjon til diabetes? 
 Hvordan vil du beskrive din kompetanse for å leve med diabetes?  
 Kontekst:Varierer du mye bruken av diabetesoppførsel ettersom hvilken 
sammenheng du er i? 
 Hvilke faktorer i behandlingsapparatet påvirker din behandling mest? 
Appendix 11: Interview guide  
 Fortell litt om din innflytelse over eget liv/sykdommen? – mestring 
 Hvordan kan helsepersonell styrke deg som diabetiker til større grad av 
mestring for egen sykdom? MAKT VS. MEDVIRKNING 
 Fortell om du kan litt om dine ønsker om å bedre din egen livssituasjon?  
 
UNDERVEIS I PROSJEKTET 
2. Kompetanse, mestring og egenomsorg 
 Fortell litt om hvordan du oppfatter prosjektet? –Si litt om opplevelsen av om 
de ble tilrettelagt for deg? 
 Fortell litt om din egeninnsats til prosjektet – Hvordan har du mestret 
prosjektet? Konsekvenser, endringer. Og evt om prosjektet har hatt noen 
betydning for deg? 
 Fortell om dine rutiner i din hverdag er noe blitt forandret? Mat, søvn, trening? -
Hvordan har prosjektet hatt innvirkning på ditt daglige arbeid med 
egenbehandling av sykdommen din? 
 Kan du si noe om din forståelse av sykdommen diabetes?  
 Si litt om mobiltelefonprosjektet i relasjon til den praktiske hverdagen som 
diabetiker.  
 Opplevelse av mestring – herunder tilgang til kunnskaper, sosiale ressurser 
eller utstyr, og evne til å utnytte disse. 
 Følelsen av anerkjennelse i forbindelse med egenmedisinering  
 Hvordan kan helsepersonell styrke deg som diabetiker til større grad av 
mestring for egen sykdom? MAKT VS. MEDVIRKNING 
 Hva tror du er viktige faktorer for at ungdommen skal la seg påvirke til bedre 
kontroll i sin hverdag (irettesettelse,trusler,ros,kommunikasjon?) 
 Hvilke faktorer i prosjektet opplevde du påvirket deg mest? SMS, 
Opplæringsbeskjeder, Dagboka. 
 
ETTER PROSJEKTET 
 Si litt om evt ønsker for å endre/ bedre din egen livssituasjon?  
 Hvordan er din motivasjon til å forsette å jobbe med diabetessykdommen? 
 Hvis du hadde fått muligheten, ville du ha fortsatt med mobilen? 
Teknikk/forbedringspotensialet 
a. Fortell om hvordan det har vært å bruke mobilen? 
b. Hva har fungert med mobilen? 
c. Hva har ikke fungert på mobilen? 
Hva kunne vært annerledes på mobilen? 
 
Noe du har lyst til tilføre? 
   
AVSLUTNING: 
 Parafrasering av det viktigste. 
Takk for intervjuet.  
Spør om det er mulig å ta kontakt igjen hvis det er noe som er uklart.  
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